Blood flow restriction training is a way of lifting light weights while a wide cuff, worn high on the arm or thigh, partly limits blood flow into the limb and slows its return. The working muscle tires far sooner than the small load alone would explain, and it grows and gets stronger in response. That pairing — a light load with a large training signal — is what draws attention to the method.

The technique was worked out in Japan in the second half of the twentieth century, spread through physiotherapy clinics and military rehabilitation units, and is now also sold as a consumer fitness product. It is used most often by people who cannot load a joint heavily: after knee surgery, during a flare of joint pain, or in later life, when tendons and cartilage tolerate less. Cuff systems range from inexpensive elastic straps to calibrated medical devices.

This review examines what the human evidence shows about the muscle, strength and physical-function changes that follow this training, what harms have been recorded and how often, how the cuff pressure and the training variables are set, and where the evidence is thin or points in opposite directions.

View Review

Sweelin is a sweetener made of protein rather than of sugar or of a small laboratory-made chemical. It is a redesigned version of a naturally sweet protein found in the West African serendipity berry, and it is brewed by yeast in fermentation tanks, the same way a growing number of food ingredients are now produced. Because it is thousands of times sweeter than table sugar by weight, the amount needed to sweeten a drink is measured in thousandths of a gram, so it adds essentially no calories.

Sweet proteins have been known since the late 1960s, but the natural forms come apart when heated or stored in acidic drinks, which kept them off supermarket shelves for decades. Protein design and fermentation changed that, and sweelin cleared a United States food-safety review, joining a small group of engineered sweet proteins already cleared there, with approvals in Singapore and Israel following.

This review examines what is actually known about sweelin: how it creates sweetness, what one human study and the animal safety work show, what the wider record on sugar substitutes suggests about the questions still open, and who paid for the evidence.

View Review

Naringin and naringenin are two closely related compounds from citrus fruit — grapefruit, orange and pomelo. Naringin is the sugar-bound form; naringenin is the same core molecule with the sugar removed. Both are sold as ingredients in creams, serums and gels aimed at firmer, brighter, less weathered-looking skin. The difference matters because the attached sugar makes naringin larger and more water-loving, which raises the question of how much of it can cross the skin’s outer layer at all.

Citrus peel has been applied to skin for centuries, and modern interest grew when laboratory work showed that both compounds calm inflammation and neutralize the damaging molecules that sunlight generates in skin. Formulators then had to choose between them, and the two are often treated as interchangeable on ingredient lists.

This review examines what is known about applying each compound to human skin: how far each one penetrates, which effects have been measured in people rather than in cells or animals, what the safety record contains, where the two compounds diverge, and how much of the published work comes from parties selling them.

View Review

MA-5 (mitochonic acid 5) is a small synthetic molecule built from the backbone of a common plant growth hormone. It was designed to make failing mitochondria produce more energy, and the proposed explanation is that it changes the shape of the folded inner membrane where energy is made rather than pushing the usual chemical reactions harder. Interest in it outside rare-disease medicine comes from a simple observation: the same loss of mitochondrial energy output that defines inherited energy disorders also accompanies ordinary aging.

The compound emerged from a Japanese screen of plant-hormone analogues chosen for their ability to raise energy levels in cultured cells. Work since then has moved it through cells taken from patients with inherited energy disorders, through worms, and through mice with kidney, hearing and movement problems. It has now reached people: an early safety study in healthy volunteers has been completed, and a placebo-controlled hospital study in patients is under way in Japan.

This review examines what MA-5 is, how it is proposed to work, what the laboratory and animal evidence establishes and what it does not, what is known and unknown about its safety, and how far it sits from ordinary use.

View Review

Noopept (omberacetam) is a small synthetic molecule built from two amino acids, developed in Russia in the 1990s as a far more potent successor to an older memory drug. It is taken by mouth in milligram doses, reaches the brain quickly, and is converted there into a peptide the brain already makes on its own. That combination of tiny doses, rapid brain entry, and a homegrown active form is why it draws interest from people trying to sharpen memory and attention.

In Russia and several neighboring countries it is a registered prescription medicine for memory and attention problems following head injury or reduced blood flow to the brain. Elsewhere it has no approval and circulates instead as a bulk powder or capsule sold online, outside any medicines regulator’s oversight. Nearly all of the research behind it comes from the single institute that created it.

This review examines what the human and laboratory evidence shows about Noopept: how it is thought to work, what effects have been measured, what harms have been recorded, how it is dosed and monitored, and how strong or weak the underlying evidence base is.

View Review

Tropisetron is a prescription anti-sickness medicine that blocks one of the receptors serotonin uses in the gut and the brainstem. It has been given for more than three decades to prevent the nausea and vomiting that follow cancer drug treatment or surgery. What draws attention beyond that role is a second action discovered years after the medicine reached the market: tropisetron also switches on a nicotine-sensing receptor found on nerve cells and on immune cells, a target tied to memory, attention and the body’s own brake on inflammation.

That dual action moved the compound out of cancer care and into trials of widespread muscle pain and of disturbed thinking and attention. The medicine is inexpensive and widely stocked across Europe and much of Asia, yet it was never brought to market in the United States.

This review examines what the human evidence shows about tropisetron’s effects and how large they are, how the compound is dosed and cleared, which of its reported actions rest on trials in people rather than on laboratory work, and what can go wrong.

View Review

ISRIB (integrated stress response inhibitor) is an experimental compound that lifts a built-in brake on protein production inside cells. When a cell is damaged, starved, infected, or simply old, it pulls this brake and sharply slows the making of new proteins. That is useful in a short emergency, but nerve cells need fresh proteins to lay down memories, so a brake left engaged for years leaves a brain less able to learn.

The compound was found by chance during a search for something else, and attention grew when mice given a few doses learned faster and old mice regained lost memory. It has since been given to animals modelling head injury, dementia, and inherited disorders of the brain’s insulating layer. No person has ever received it in a registered clinical trial, yet it is sold as a research chemical and a few people with a fatal nerve disease have taken it themselves.

This review examines what is established about ISRIB: how it acts on cells, what the animal and laboratory evidence does and does not show, how related compounds have performed in people, which measures the literature ties to tracking its effects, and who paid for the work.

View Review

NSI-189 (also known as amdiglurax or ALTO-100) is an experimental oral compound designed to do something no marketed antidepressant does directly: prompt the brain to grow new nerve cells in the region most closely tied to memory and mood. It does not act on serotonin or the other chemical messengers that conventional mood medications target.

Interest in it grew out of a long-standing idea that when this brain region loses its capacity to renew itself, low mood and the mental fog that often accompanies it follow. Early human testing suggested improvements in both mood and thinking, and the compound was taken by mouth and well tolerated. On that strength it moved from a laboratory candidate into wide unregulated sale to people experimenting on themselves, years before its testing was finished.

This review examines what the human and animal evidence shows about NSI-189: how it is thought to work, which of its claimed effects have held up under placebo-controlled testing and which have not, what is known about its safety and the doses used, and where the uncertainty still lies.

View Review

ACD856 is an experimental oral compound built to strengthen the brain’s own growth-signaling system. Nerve cells depend on a small family of proteins that keep them alive, help them build connections, and support memory. ACD856 does not supply those proteins. It makes the docking points they act on respond more strongly to whatever signal is already there. The approach draws interest because this signaling weakens with age and is reduced in several brain disorders.

The compound came from an unlikely starting point. A screening program run by a small Swedish company found that two veterinary antiparasitic medicines could boost this signaling, and chemists reshaped them into a molecule suited to the human brain. It has since been given to healthy volunteers in early studies, and preparation for testing in patients is under way.

This review examines what is established about ACD856: how it is thought to work, what the laboratory and animal work shows, what the early human studies did and did not measure, and where the evidence runs out.

View Review

Phenylpiracetam is a laboratory-made compound built by adding a small carbon ring to piracetam, the first substance ever sold as a memory drug. The change makes it much more fat-soluble, so it reaches the brain quickly and works at far smaller amounts. In Russia and a few neighbouring countries it is a licensed prescription medicine for lasting fatigue; almost everywhere else it is an unapproved substance traded informally as a thinking aid. Unlike most of its chemical relatives, it feels stimulating.

Its roots lie in Soviet research on keeping cosmonauts, pilots and soldiers working under extreme strain, and that reputation for boosting stamina eventually led sporting authorities to ban it. Most of the clinical research is still Russian-language work published over four decades and rarely repeated elsewhere, while the compound has quietly become a fixture of the online market for brain supplements.

This review examines what the human and laboratory evidence shows about phenylpiracetam’s effects, how it appears to work, the doses and treatment courses used in clinical practice, its side effects and interactions, the independence and quality of the research behind it, and the practical and legal position it occupies outside Russia.

View Review

Phenylpropylaminopentane is an experimental laboratory compound made by chemically reshaping selegiline, a prescription drug used in Parkinson’s disease. Its designers deliberately removed the enzyme-blocking action selegiline is known for and kept a second, subtler property: making nerve cells release a larger burst of dopamine and noradrenaline each time an electrical signal arrives, instead of emptying their stores at random the way older stimulants do.

That distinction is what drew attention. The Hungarian laboratory that created the compound argued that this release-amplifying signal fades steadily after young adulthood, and that restoring it might slow the loss of learning ability, drive, and vitality that follows. In rodents the compound improved learning, blunted chemically induced apathy, and worked across a wide dose range without the repetitive, agitated behaviour typical of amphetamines.

This review examines what is actually known about phenylpropylaminopentane: how it is thought to work, what the animal and laboratory record shows, how it compares with better-studied molecules in the same family, and what has never been measured. The compound has never been given to a person in a published study, and that gap frames every finding below.

View Review

Chaga is a black, charcoal-like fungal growth that forms on living birch trees across Siberia, Northern Europe, Canada, and the northern United States. Harvesters cut the woody mass from the trunk, dry it, and grind it into a powder that is brewed as a dark tea or packed into capsules. Interest in it comes from an unusually dense mix of fungal fibers, fat-soluble compounds, and dark pigments that laboratory work links to inflammation control and blood sugar handling.

Northern peoples have used chaga for centuries as a daily beverage and a remedy for stomach complaints and visible growths, and Soviet health authorities approved a chaga extract as a registered medicine in the 1950s. It has since become one of the best-selling functional mushroom products in the consumer supplement market, usually sold for immune support, energy, and healthy aging.

This review examines what is actually established about chaga: what its compounds appear to do, how much of that comes from people rather than from cells and animals, what harms have been recorded, and how those two sides weigh against each other.

View Review

BPN14770 is an experimental oral drug that partially blocks one narrow form of an enzyme brain cells use to clear away a short-lived signalling molecule involved in learning and memory. By slowing that clearance, it is meant to strengthen the chemical messages that help nerve cells build and keep their connections. It was deliberately designed to bind at an unusual site and to switch the enzyme down only part of the way, in the hope of avoiding the nausea that halted earlier drugs of the same family.

The compound grew out of work on fragile X syndrome, an inherited condition that causes intellectual disability, and it carries a special regulatory status for that use. It has since been tested in people with early Alzheimer’s disease, in healthy older volunteers, and in a second rare genetic condition. Interest beyond those groups rests on the claim that the same signalling pathway supports memory in ordinary aging.

This review examines what the human and animal evidence actually shows: what the drug does, how large and how repeatable the reported effects are, what harms have been recorded, and what is still unknown.

View Review

Desoxyn is the brand name under which methamphetamine hydrochloride was sold as a prescription medicine in the United States. Most people know the molecule only as an illegal street drug, so its status as an approved, dose-controlled tablet is unfamiliar. Taken by mouth at prescribed strengths, it increases signalling by dopamine and norepinephrine in the brain.

Its history is long. Armies on several sides distributed it during the Second World War against fatigue, it was sold for decades as an appetite suppressant, and it stayed approved for childhood attention deficit hyperactivity disorder long after prescribers had moved to other stimulants. Today it is a very small share of stimulant prescriptions, and only generic tablets remain. For a reader weighing it against long-term health rather than a diagnosis, the question is narrower: how a sustained push on alertness sits alongside its effects on sleep, blood pressure and the brain over decades.

This review examines the published evidence on methamphetamine hydrochloride as a prescribed medicine: how it acts in the body, which benefits have been measured and how firmly, which harms are documented at prescribed and higher exposures, and how the prescribed form compares with the illicit one dominating public discussion.

View Review

Vyvanse is a prescription stimulant that the body must break apart before it does anything. The swallowed molecule is inert; an enzyme inside red blood cells slowly cuts it into an amino acid and an active amphetamine. Because that cutting step sets the pace, the drug’s effect builds gradually and lasts most of a working day instead of arriving as a spike. It is licensed for persistent attention and impulse-control problems in children and adults, and for moderate to severe binge eating in adults.

Amphetamine-type medicines have been prescribed since the 1930s, and this one was engineered decades later specifically to be useless if crushed, snorted or injected. It is now among the most widely dispensed stimulants in several countries, and it is taken daily for years rather than weeks. For anyone thinking in terms of long-term health rather than a semester or a quarter, that duration is the interesting part.

This review examines what the evidence shows: how Vyvanse works, what it measurably changes, what it costs in sleep, appetite, blood pressure and long-term heart risk, how it is dosed, monitored and stopped, and where the research remains open.

View Review

Humulin R is a laboratory-made copy of the insulin the human pancreas produces, sold as an injectable solution. It was the first medicine ever manufactured using genetic engineering, and it remains one of the least expensive insulin products on the market. Because insulin governs how the body stores fuel, builds tissue and manages blood sugar, it sits at the center of both diabetes care and long-running questions about metabolism and lifespan.

Human insulin dominated diabetes treatment for roughly two decades before modified versions — designed to act faster or last longer — displaced it. Those newer products became far more expensive, and a share of people who need insulin have since returned to the older formulation for reasons of cost and availability. At the same time, researchers studying aging have taken a strong interest in insulin itself, since lower lifetime insulin exposure tracks with longer life in a range of species.

This review examines what the evidence shows about Humulin R: how it works, where it performs comparably to newer insulins and where it does not, the risks that come with injecting it, how it is dosed and monitored, and what is known and unknown about long-term insulin exposure.

View Review

Cerebrolysin is an injected preparation of small protein fragments and free amino acids obtained from purified pig brain tissue. Its makers describe it as imitating the body’s own nerve-growth signals — the molecules that keep brain cells alive, help them build new connections, and drive repair after injury. That places it in an unusual category: not a vitamin, not a stimulant, but a biological preparation aimed squarely at the brain’s capacity to maintain and rebuild itself.

It has been made in Austria since the middle of the last century and is prescribed today in more than fifty countries for stroke, head injury, and dementia, though it has never been licensed in the United States. Alongside those approved uses it has acquired a second life among people who take courses of it hoping to sharpen thinking or slow brain ageing.

This review examines what the clinical record shows: where the trial evidence is firm, where it is contested, who paid for it, what a course of treatment actually involves, and what is known — and not known — about giving it to people who are not ill.

View Review

Aniracetam is a laboratory-made compound from the racetam family, a group of substances first developed in the 1960s and sold in several countries as memory medicines. It dissolves in fat rather than water, reaches the brain quickly, and is taken by mouth. Interest in it comes from reports that it sharpens focus and recall while also easing tension, a combination that few compounds claim.

It was approved decades ago in parts of Europe and Asia for the mental and emotional symptoms that follow a stroke or accompany dementia, then later lost that standing in at least one market. Today it is sold mainly through the grey market for brain supplements, where it is not an approved ingredient and where laboratory testing has repeatedly found it in products that do not list it.

This review examines what is actually known about aniracetam: how it acts in the brain, what the human trials measured and where they disagree, what is known about safety, dosing, sourcing, and monitoring, and how far any of it extends to adults who already function well and are looking to protect memory and mood as they age.

View Review

PAI-1 inhibitors (plasminogen activator inhibitor-1 inhibitors) are experimental oral medications built to block one protein. That protein is the body’s main brake on the system that dissolves blood clots, and it also drives scar tissue formation and pours out of worn-out cells that have stopped dividing but refuse to die. Its levels climb with age, with body fat, and with long-running inflammation.

Interest in switching it off grew out of an unusual natural experiment. In a genetically isolated farming community in Indiana, one extended family carries a rare mutation that halves production of the protein. Carriers turned out to live longer than their relatives, with longer chromosome end-caps and no diabetes. In parallel, a Japanese university group had spent two decades turning a computer-designed molecule into an oral drug that has now reached late-stage cancer trials.

This review examines what is known about blocking this protein in people: how the compounds work, which effects have actually been measured in completed trials, what remains laboratory and animal work only, the safety signals reported so far, and who paid for the evidence.

View Review

Cardiogen is a laboratory-made peptide: a chain of just four amino acid building blocks, assembled in Russia as one of a family of compounds each aimed at a single organ. Cardiogen’s assigned organ is the heart. The idea behind it is that very short peptides normally present in tissue carry instructions to the cells around them, and that supplying the heart’s own signal might restore how an ageing heart maintains and repairs itself.

The family grew out of Soviet military medical research in the 1970s on extracts taken from animal organs; synthetic four-amino-acid versions followed, and they now sell worldwide as freeze-dried powder in vials labelled for laboratory use only. Almost everything published on Cardiogen itself comes from the single research institute that created it, and none of that work involved people.

This review sets out what is known about Cardiogen: the biology proposed for it, the studies behind each claimed effect and each claimed harm, how far the protocols in circulation rest on that evidence, and which markers a person tracking cardiovascular ageing could follow.

View Review

Pancragen is a synthetic peptide built from four amino acid building blocks and directed at the pancreas, the organ that releases insulin and digestive enzymes. It was designed in Russia as a signaling molecule rather than a hormone: the claim attached to it is that it enters the cell nucleus and adjusts which genes the pancreas reads, rather than acting on a surface receptor the way a drug normally does.

It belongs to a family of short peptides first extracted from animal organs by Soviet researchers in the 1970s and later reproduced synthetically. Within Russia and neighbouring countries these preparations are registered as supplements and used in clinical practice; elsewhere they reach people almost entirely through online sellers. Attention has followed the observation that blood sugar regulation tends to drift as people get older, and the pancreas is where that drift begins.

This review examines what is established about Pancragen and what is not: its composition, the proposed mechanism, what laboratory, animal and human studies actually report, where the evidence is thin or comes from a single source, and what risks and practical limits accompany its use.

View Review

Cartalax is a laboratory-made peptide built from three amino acids, the small building blocks that make up proteins. It was designed in Russia as a messenger aimed at cartilage and the connective tissue around joints, and it is meant to work by nudging cells back toward a younger pattern of activity rather than by blocking a receptor or replacing a hormone.

It belongs to a family of very short peptides that grew out of Soviet-era work with extracts from animal organs, later reduced to synthetic copies of their smallest active fragments. Cartalax is the synthetic counterpart of the cartilage extract in that line. Nearly all published work on it comes from one institute in St. Petersburg, and outside Russia it is sold as a research chemical rather than as an approved medicine.

This review examines what is actually known about Cartalax: how it is proposed to act on joint tissue, what the published experiments measured and in which systems, what has never been tested in people, and what the sourcing and quality questions are.

View Review

Chonluten is a synthetic peptide only three amino acids long, one of a family of tissue-targeted peptides developed in Soviet and later Russian laboratories. It is sold as the lung and airway member of that family, on the claim that each peptide carries a signal read by one particular organ. Interest among people focused on healthy aging comes from that claim: that a molecule small enough to enter a cell nucleus could nudge the genes governing airway tissue toward a younger pattern.

The family grew out of work begun in the early 1970s on extracts taken from animal organs, which were later broken down and rebuilt as short synthetic sequences. Chonluten is registered in Russia as a food supplement rather than a medicine, and elsewhere it circulates mainly through laboratory-chemical suppliers. Its name is also used for an older capsule product made from cattle lung tissue, so two quite different preparations share one label.

This review examines what the evidence shows about Chonluten: what the molecule is, how it is proposed to act, which effects have actually been measured and in what systems, what risks and unknowns attach to it, and how it is used in practice.

View Review

Livagen is a laboratory-made chain of four amino acid building blocks, one of a family of very short peptides created in Russia from the 1970s onward on the idea that a small fragment copied from an organ’s own regulatory proteins can signal back to that organ and restore its youthful pattern of activity. Livagen was designed from liver tissue, and its proposed action is to loosen tightly packed regions of the cell’s genetic material so that genes switched off with age can be read again.

The wider family, usually called peptide bioregulators, has an unusual history: it grew out of Soviet military medicine, produced hundreds of publications and several products sold inside Russia, and has remained almost entirely separate from Western drug development. Livagen itself has never been given to people in a registered study, yet it is bought today by people pursuing a longer healthspan, almost always through unregulated online sellers.

This review examines what has actually been measured for Livagen, how far that evidence reaches, where it stops, and what the practical, sourcing and safety questions are for anyone weighing it.

View Review

Vesugen is a synthetic peptide made of just three amino acids — lysine, glutamic acid and aspartic acid — sold as a supplement aimed at the lining of blood vessels. It comes from a Russian family of very short peptides marketed as “bioregulators”, built on the idea that a fragment this small can enter a cell nucleus and shift the activity of a few specific genes back toward a younger pattern.

The compound was created at a St. Petersburg gerontology institute in the late 1990s, patented in Russia in 2007 for improving the resilience of small blood vessels, and has been sold there ever since as a food supplement. It has never been approved as a medicine anywhere, and outside Russia it circulates mainly through laboratory-chemical suppliers whose labels say it is not for human use.

This review examines what has actually been measured: the laboratory findings behind the blood-vessel claims, the small human studies run almost entirely by the group that created and sells the compound, what is known and unknown about how it behaves in the body, and how the supply channel shapes what someone would in practice be taking.

View Review

Cortexin is an injected medicine made from a purified extract of cattle brain cortex — a mixture of small protein fragments, free amino acids and trace minerals. It is sold in Russia and neighbouring countries as a brain-protecting treatment and reaches people elsewhere through import channels. Interest among longevity-minded adults comes from the claim that a short course of injections can sharpen thinking and lift fatigue that has resisted other approaches.

The preparation was developed inside the Soviet military medical system in the 1980s and licensed as a civilian medicine at the end of the 1990s. Since then it has been given to very large numbers of patients across that region, mostly after strokes and in long-standing circulatory brain disease. Almost all of the published human experience comes from that one region, and much of it was funded by the company that makes the product.

This review examines what the available human and laboratory evidence shows about Cortexin: what it appears to do, how large the reported changes are, what harms have been recorded, how it is dosed and cycled, and how much weight the underlying research can carry.

View Review

Thymogen is a laboratory-made molecule built from just two amino acids — glutamic acid joined to tryptophan. It was originally pulled out of a natural extract of calf thymus, the small chest gland that trains the body’s immune cells, and then copied by chemical synthesis. Interest in it rests on a simple idea: if a single small fragment of thymus signalling can be given back, perhaps some of the immune capacity lost with age can be recovered.

The thymus shrinks steadily from adolescence onward, and much of the decline in immune resilience across a lifetime tracks that shrinkage. Thymogen has been a registered medicine in Russia since around 1990, sold as a nasal spray, an injection and a skin cream, while the identical molecule was developed separately in the United States under a different name and tested in cancer. The molecule therefore carries two largely separate research records.

This review examines what the published evidence shows about Thymogen — how it is thought to work, what outcomes have been measured in people and in animals, what harms have been recorded, how it is dosed, and how much weight the underlying studies can carry.

View Review

Thymalin is a mixture of small protein fragments extracted from the thymus glands of young calves. The thymus is the small gland behind the breastbone where developing immune cells learn to tell the body’s own tissues from invaders. It shrinks steadily from adolescence onward, and much of the weakening of immune defence in later life tracks that shrinkage. Thymalin was built on the idea that returning thymus-derived signals to an older body might restore part of what is lost.

It has been a registered injectable medicine in Russia and neighbouring countries for more than four decades, given to help the immune system recover after burns, surgery, severe infection and radiation exposure. Long-term follow-up of older adults reported fewer respiratory illnesses and longer survival — a claim never tested outside the region where the compound was developed.

This review examines what the published record does and does not establish: how Thymalin is thought to act, which benefits and harms have been recorded, how it has been dosed, how it can be obtained, and what would need to be measured to tell whether it is doing anything.

View Review

Epithalamin is a mixture of small proteins drawn from the pineal gland of cattle — the pea-sized gland in the brain that makes melatonin and helps set the body’s daily rhythm. Researchers in what was then Leningrad developed it in the early 1970s as an injectable preparation meant to restore signals that this gland loses with age. It draws attention because pineal output falls steeply after midlife, and because the same laboratory later reported that older people given repeated courses lived longer than untreated comparison groups.

The preparation has been used in clinical practice in Russia and Ukraine for decades and is sold internationally as a longevity injection, yet nearly the entire published record comes from one research network, and no regulator outside the former Soviet Union has assessed it. A synthetic four-part copy of one active fragment is now the form most people encounter, which makes the two easy to confuse.

This review examines what the human and animal record shows: what Epithalamin is made of, how it is thought to work, what has been measured in people, what is known about its safety, and how strong or weak the support behind each claim is.

View Review

Cortagen is a laboratory-made peptide of four amino acids: alanine, glutamic acid, aspartic acid and proline. It was designed in Russia to reproduce, in one defined molecule, the active fraction of an older brain-tissue extract long used there in neurology. Interest in it comes from an unusual proposal: that a molecule this small enters the cell nucleus and changes which genes a cell reads, instead of acting on a receptor at the cell surface as most drugs do.

It belongs to a family of very short peptides developed from the 1970s onward at a St. Petersburg research institute, each one matched to a particular organ; Cortagen is the brain-cortex member. Most of what has been published on it concerns nerve repair and the brain’s response to poor blood supply in animals, and nearly all of it comes from the same circle of laboratories.

This review examines what Cortagen is, how it is proposed to work, what the published record does and does not show, how it has been used, and where the evidence stops.

View Review

Empagliflozin (sold as Jardiance) and canagliflozin (sold as Invokana) are two oral medications that make the kidneys pass sugar out in the urine instead of returning it to the blood. Both were developed for type 2 diabetes, and both were later shown to protect the heart and the kidneys in people who take them over years.

Interest in the pair outside diabetes care has two roots. Large outcome studies found that each drug lowered the rate of heart and kidney events, in some cases in people without diabetes at all. Separately, a rigorous animal aging program found that canagliflozin lengthened the lives of male mice — something empagliflozin has never been tested for — which turned the choice between the two into a live question for people taking either drug with long-term health in mind.

This review examines what the published evidence shows about how the two differ: how each acts inside the body, which benefits and harms have actually been recorded in people, where their safety signals diverge, and what is known about their practical use. It also marks the places where the evidence is too thin to separate them.

View Review

Empagliflozin, sold as Jardiance, is an oral prescription medicine that makes the kidneys flush part of the body’s sugar out in the urine instead of returning it to the blood. It was built as a diabetes drug. Its most striking results, however, have come in the heart and the kidneys, in people who have diabetes and in people who do not. A sugar-handling drug that protects organs by routes largely unrelated to sugar is an unusual thing, and that is why it now draws attention well beyond diabetes clinics.

The drug reached pharmacies in 2014. Early large-scale testing reported fewer deaths among the people taking it, a finding that reshaped how the whole family of drugs was viewed. Since then it has been tested in heart failure, in kidney disease, and after heart attacks, while animal work has raised a further question: whether medicines of this type reach the machinery of ageing itself.

This review examines what the evidence shows about empagliflozin’s effects, the harms recorded alongside them, how it is dosed, sourced and monitored, and where the record is thin, contested, or shaped by who paid for it.

View Review

Kylo-11 is an experimental injectable drug designed to switch off the liver’s production of lipoprotein(a), a cholesterol-carrying particle in the blood whose level is set almost entirely by inherited genes. Unlike most blood fats, lipoprotein(a) barely moves with diet, exercise, or weight loss, and no approved medicine lowers it as its main purpose.

Roughly one in five people worldwide carries a high level, and that level tracks with earlier narrowing of the arteries and with stiffening of the heart’s aortic valve. For decades this was a number a person could measure but not change. A wave of gene-silencing injections has changed that, and Kylo-11 belongs to this wave; its distinguishing claim is that a single injection may hold the level down for about a year.

This review examines what is known about Kylo-11: how it works, what its early human testing has shown, what remains untested, what risks are plausible, and how it compares with the other gene-silencing drugs aimed at the same target.

View Review

Ampelotherapy — known in English as the grape cure — is the practice of eating large quantities of fresh grapes, sometimes to the near-exclusion of all other food, for a fixed span of days or weeks. It draws attention because grapes are unusually rich in the colored plant compounds that have been studied for effects on blood vessels, blood sugar and the gut, and because the practice concentrates that intake far beyond anything an ordinary diet delivers.

The practice was formalized at German and Italian spa towns in the nineteenth century, where guests spent several autumn weeks on a supervised grape diet alongside walking and light meals. In the 1920s the same diet was recast as a cancer remedy, and it has been argued over ever since — kept alive in wellness circles, rejected by cancer organizations.

This review examines what is known about eating grapes in therapeutic quantities: how the practice has actually been carried out, what controlled human research on grapes and grape products shows, where that research stops, and what a weeks-long grape-dominant diet does to the rest of a person’s nutrition.

View Review

Bifidobacterium pseudocatenulatum (B. pseudocatenulatum) is one of the bacteria that lives naturally in the human large intestine. It belongs to the bifidobacteria, the group that dominates the infant gut and thins out steadily with age. Unlike the handful of bifidobacteria sold in yogurts and capsules for decades, this species has only recently been cultivated and studied as a supplement in its own right.

Interest grew from where the organism turns up. Surveys of gut bacteria find it more often, and in larger amounts, in people who have reached very old age in good health, in people eating mostly plants, and in adults whose blood markers of inflammation are low. Laboratory and animal work suggests it feeds on plant fibers that human digestion cannot break down, and reshapes bile chemistry and immune signaling in the gut wall.

This review examines what is known about B. pseudocatenulatum as a deliberate intervention rather than as a passenger: how it works, what has been measured in people who have taken it, what has been measured only in animals or cells, what could go wrong, and how anyone attempting to raise its numbers would go about it and track the result.

View Review

Apitegromab is a laboratory-made antibody, given by infusion, that blocks myostatin — the body’s own brake on muscle growth. Muscle does more than move the body: it stores sugar, shapes metabolism, and tracks closely with how well people function as they age. A medicine that adds or protects muscle without hormones or heavy training is therefore of obvious interest to anyone thinking about the long arc of health.

The idea is not new. For nearly three decades, drug developers tried to switch off this brake and repeatedly came up short: some compounds hit related signalling proteins and caused unwanted effects elsewhere, while others added bulk that never turned into strength. Apitegromab was engineered to be far more selective, and it is the first of its kind to improve movement in a controlled disease trial and to hold on to lean tissue in people losing weight on modern appetite-lowering medicines.

This review examines what apitegromab does and how, the strength of the evidence behind its claimed benefits and its harms, how it is dosed, sourced and monitored, and where the open questions still sit.

View Review

ATX-304 is an experimental oral medication built to switch on the enzyme that cells use to detect when their fuel is running low. The same switch is thrown by hard exercise and by going without food, so a compound that flips it directly has drawn attention from people who follow the biology of aging and who already train, fast, and track their own metabolic markers.

The molecule was discovered in Sweden and first developed as a treatment for type 2 diabetes. It has since been carried forward for obesity and related disorders of metabolism, and it has been given to people in two short, company-run studies. Only a handful of compounds reach this cellular switch directly rather than by making cells work harder for energy, and ATX-304 is the first of that group to produce measurable metabolic changes in humans.

This review examines what is known about ATX-304: how it is thought to work, what was measured in laboratory animals and in the people who have taken it, what the safety record covers and what it does not, how it has been dosed in trials, and where the evidence base is thin or contested.

View Review

Red clover extract is a concentrated preparation made from the flowering tops and leaves of a common meadow legume, standardized for plant compounds called isoflavones. These compounds resemble the body’s own estrogen closely enough to switch on some of the same cell receptors, which is why the extract is taken during and after the menopausal transition, when falling estrogen drives heat surges, shifts in blood fats, stiffer arteries and faster bone loss.

The plant has centuries of use as forage and as a folk remedy, and its hormone-like activity was first noticed in grazing sheep that became infertile on clover-rich pasture. Standardized capsules reached consumers in the late 1990s and were marketed as a gentler option than prescription hormone therapy once safety worries about hormones became widely publicized. Dozens of controlled trials have followed, funded both by the companies selling the extract and by public research agencies, and they do not all agree.

This review examines what that body of evidence shows about the effects of red clover extract, where findings are consistent and where they conflict, what is known about its safety and its interactions with medicines, and how it is dosed, sourced and monitored.

View Review

Rose hip is the fruit that forms on a rose bush after the petals drop. The fruit of the dog rose, Rosa canina, is the type most often dried, milled to a powder, and sold as a supplement. It is one of the richest plant sources of vitamin C and also carries plant pigments, fruit acids, and a fat-like compound in the seeds and shells that appears to quiet inflammation.

Rose hips have been brewed as tea and used as a household remedy across Europe and Asia for centuries, and were gathered on a national scale in wartime Britain to make a syrup when citrus fruit could not be imported. Modern clinical interest began when a standardized powder made from the whole fruit, seeds and shells included, was developed in Denmark and tested in people with painful joints.

This review examines what rose hip is, how it is thought to act in the body, what controlled human trials show for joint symptoms, body composition and blood cholesterol, what its safety record looks like, how preparations differ, and who paid for the research.

View Review

Mucuna pruriens (velvet bean) is a climbing tropical legume whose seeds contain unusually large amounts of levodopa, the substance the brain converts into dopamine, a chemical messenger tied to movement, drive and hormone control. Because the plant delivers a genuinely active drug rather than a mild botanical, it sits in an unusual space between food, traditional medicine and pharmacy shelf.

The bean has been used in traditional Indian (Ayurvedic) medicine for centuries as a nerve tonic and reputed aphrodisiac, and it is still grown across the tropics as a food and cover crop. Modern interest grew once researchers confirmed that roasted seed powder behaves much like the standard prescription treatment for Parkinson’s disease, and it is now sold widely as a mood, drive and fertility supplement.

This review examines what the human and animal evidence shows about Mucuna pruriens: how it works, which outcomes have actually been measured, what harms have been reported, how it is prepared, dosed and monitored, and where the evidence remains thin or contested.

View Review

Evening primrose oil is pressed from the seeds of a North American wildflower and sold worldwide as a supplement. What sets it apart from ordinary seed oils is a small fraction of an unusual fat that the body normally has to build for itself, using a conversion step that runs slowly in many people. The idea behind supplementing is simple: supply that fat directly, and the body can make more of the signalling molecules that damp down inflammation.

The plant was food and wound medicine for Indigenous peoples of North America, and the oil became one of the best-selling botanical products in Britain and Europe during the 1980s and 1990s, when it was licensed as a medicine for eczema and for cyclical breast pain. Those licences were later withdrawn, sales as a supplement continued, and new uses appeared in maternity care.

This review examines what controlled human research shows about evening primrose oil: where it moves measurable outcomes and where it does not, how solid each body of evidence is, who paid for it, and what is known about dosing, safety, and product quality.

View Review

Rooibos is a caffeine-free herbal infusion brewed from the leaves and stems of a broom-like shrub that grows in a single mountainous corner of South Africa’s Western Cape and nowhere else. It carries almost none of the bitter tannins of ordinary tea, and it contains a flavonoid called aspalathin that has been found in essentially no other edible plant. That combination — a pleasant everyday drink that also delivers an unusual plant chemistry — is why a beverage first sold commercially a little over a century ago now sits in the health aisle.

The plant was gathered by the region’s indigenous inhabitants long before it was cultivated, and interest in it as a health product grew after mid-century claims about soothing effects in infants drew researchers in Japan and South Africa to study it. Human trials, however, remain few and small, and much of the enthusiasm rests on laboratory and animal work.

This review examines what controlled human data, mechanistic work, and safety reports show about rooibos — what changes it produces, how large those changes are, where the evidence conflicts, and what remains untested.

View Review

Beer’s bitterness comes from resins in the flower of the hop plant. When those resins sit in storage, or are heated on purpose, they oxidize into a second family of bitter compounds — softer on the tongue and, as it turns out, biologically different from the bitter compounds that brewing itself creates. Matured hop extract is the concentrated, standardized form of that oxidized fraction, sold as capsules and added to some alcohol-free beverages.

Interest in it began with weight research in Japan, where drink makers wanted a food ingredient that could shrink abdominal fat without the harsh taste of the brewing-derived bitters. A second line of work followed from a different idea: that bitter compounds sensed in the gut can send a signal up the nerve connecting gut and brain, and that this signal might sharpen attention and steady mood.

This review examines what matured hop extract is, how it is thought to act, what the human and animal studies report about abdominal fat, thinking, and mood, what is known about its safety, and how it has been dosed and monitored.

View Review

Dong quai is the dried root of a tall flowering plant in the carrot family that grows in the cool mountain regions of China, Japan, and Korea. It has been prepared as both food and medicine for roughly two thousand years, most often simmered in soups, steeped in wine, or boiled together with other roots in a shared pot rather than swallowed on its own. Modern supplement shelves present it very differently: as a single-ingredient extract sold for women’s hormonal health, circulation, and energy.

That shift from shared kitchen ingredient to solo capsule sits at the center of the argument about it. Traditional practice almost never used the root by itself, so the small number of Western trials that tested it alone tested a preparation that traditional practitioners would not recognize. The root carries compounds that discourage blood clotting alongside compounds that faintly imitate the body’s own estrogen, which means its promise and its cautions grow from the same chemistry.

This review examines what human and laboratory work shows about dong quai’s effects on menstrual pain, menopausal symptoms, and blood building, where its risks lie, and how the single-herb and multi-herb forms differ.

View Review

Safranal is the small, strongly scented molecule that gives saffron its characteristic aroma. It is barely present in the fresh flower; it forms as the harvested threads are dried, and laboratories measure it as one of the two markers used to judge whether a batch of saffron is genuine. It dissolves in fat, reaches brain tissue in animals, and in laboratory work it quiets the signals that drive inflammation and limits the wear that unstable oxygen molecules cause inside cells.

Saffron itself has been used for low mood, restless sleep and pain for well over two thousand years. The extracts sold today for mood support are standardised to a declared safranal content, so a spice aroma compound has become a named, measured ingredient on supplement labels — taken daily in concentrated form rather than eaten in the quantities a kitchen delivers.

This review examines what is established about safranal specifically: the pathways it acts on, what animal and human studies report for benefit and for harm, how much of it the standardised extracts actually deliver, and where evidence for the isolated compound ends and evidence for whole saffron begins.

View Review

Ecklonia cava is an edible brown seaweed that grows on rocky coastal beds in Korea and Japan, where it has long been eaten as food. It is unusually rich in polyphenols — the same broad family of plant compounds found in green tea and red wine — and concentrated extracts of these compounds are now sold worldwide as capsules and powders.

Interest grew after laboratory work showed that the seaweed’s polyphenols are strong antioxidants and can slow the digestion of starch and sugar. Purified extracts have since been cleared for sale as a supplement ingredient in Europe, the United States and Korea, and marketed for blood sugar, cholesterol and sleep — the kind of measures people tracking their long-term health watch closely. How much human testing sits behind each claim varies widely.

This review examines what controlled human studies, regulatory safety assessments and independent product testing show about Ecklonia cava: which effects have actually been measured in people, how large they are, what the extract’s poor absorption implies for anyone swallowing it, and which hazards attach to seaweed-derived products.

View Review

Acerola is a small red cherry-like fruit from a shrub native to the Caribbean, Central America, and the north of South America, where it has long been eaten fresh or pressed into juice. Its claim to attention is how much vitamin C it holds: gram for gram, the ripe fruit carries roughly fifty to a hundred times more than an orange, which makes it one of the densest food sources of the vitamin known. It is sold today mainly as a dried juice powder, a frozen pulp, or a capsule.

Brazil turned the fruit into a commercial crop in the late twentieth century, and acerola powder is now a common ingredient in supplements and functional drinks that advertise “whole-food” or “natural” vitamin C in place of the manufactured form. Marketing built on that distinction has run well ahead of what has been measured in people, and the fruit also carries red pigments and other plant compounds whose role is still being worked out.

This review examines what the evidence shows about acerola: what it delivers, what it does not, where the data are thin, and where the trade-offs sit.

View Review

Maqui berry is a small, dark purple fruit from the temperate rainforests of southern Chile and Argentina. It carries an unusually dense load of the deep-pigment compounds that give berries their color, and one of them, called delphinidin, is present at levels rarely matched by other fruits. That pigment profile is the reason a regional wild berry became an internationally traded supplement ingredient.

The Mapuche people of southern Chile have eaten the fruit and brewed its leaves for centuries, using both as an astringent remedy and a fever treatment. Modern interest arrived with the wave of tropical superfruit products in the 2000s, and two standardized extracts were later developed and tested in small human trials, one aimed at tear production and eye comfort, the other at blood sugar after meals.

This review examines what the human and laboratory evidence shows about maqui berry: the size and quality of the trials behind its two main claims, the mechanisms proposed for them, what is known and not known about safety, how products differ, and who funded the research.

View Review

Delphinidins are the deep blue-purple pigments that color bilberries, blackcurrants, eggplant skin, dark grapes, pomegranate, and the Chilean maqui berry. They sit within the wider family of water-soluble plant colors found across fruits and vegetables, and they carry more oxygen-hydrogen groups on their outer ring than their relatives do, which makes them the strongest free-radical scavengers of that family in laboratory tests. Concentrated berry extracts standardized for delphinidin content are now sold as capsules.

Attention grew after Chilean and Japanese research groups reported that concentrated maqui extracts blunted the rise in blood sugar following a meal and increased tear production in people with dry, tired eyes. Separately, large diet surveys have repeatedly found that people eating more of these pigments have lower rates of heart and blood-sugar disease, although surveys of eating habits cannot by themselves show that one causes the other.

This review examines what is established about delphinidins: how much reaches the bloodstream and how quickly it leaves, which effects survive controlled human testing and which rest on cell and animal work, what doses and forms have been used, what could go wrong, and how far the evidence is shaped by who funded it.

View Review

Chlorophyllin is a laboratory-modified form of chlorophyll, the pigment that makes plants green. Replacing the magnesium at the center of the molecule with copper, and trimming off its greasy tail, turns a fat-soluble pigment into a water-soluble green powder. Interest in it rests on one physical property: the flat molecule clamps onto other flat molecules, including several potent cancer-causing chemicals in moldy grain and charred meat.

Surgeons used it on slow-healing wounds in the 1940s, and it has been sold ever since as a non-prescription internal deodorant. Animal work then suggested it could block the uptake of a mold poison that drives liver cancer in parts of Asia and Africa, and a study in one such region moved chlorophyllin from folk remedy to a subject of serious cancer-prevention research.

This review examines what chlorophyllin does in the human body, how far the evidence extends beyond laboratory and animal work, which of its marketed uses rest on controlled data and which do not, what dosing schedules have actually been tested, and what the copper it carries and its light-absorbing chemistry mean for people who take it for years as part of a long-term health strategy.

View Review

Celery seed extract is a concentrated preparation made from the small aromatic fruits of the celery plant rather than from its familiar stalks. The seed carries most of the plant’s pharmacologically interesting chemistry, and a single capsule delivers far more of it than anyone could obtain by eating the vegetable. Commercial products are standardized to a fat-soluble aroma compound that is found in almost no other food.

Celery seed has a long record in Ayurvedic, Persian, and European herbal practice as a remedy for joint pain, swelling, and urinary complaints. In China, a single purified compound isolated from celery seed oil was developed into an approved medicine for stroke, giving the plant an unusual dual identity as both kitchen spice and pharmaceutical starting material. Small controlled trials in people with high blood pressure later renewed commercial interest in the whole extract.

This review examines what the human and animal evidence shows about celery seed extract for blood pressure, blood fats, and uric acid; the allergy and safety questions it raises; how it is dosed, sourced, and monitored; and how much confidence the underlying research supports.

View Review

Punarnava (Boerhavia diffusa) is a sprawling weed that grows through much of India, Africa and the tropical Americas, where its thick root has been dried and taken as medicine for well over two thousand years. Its Sanskrit name means “renewer” — a reference to the way the plant appears to die back in the dry season and revive with the rains, and to the classical claim that it renews the body. It is best known as a mild herb for shedding excess body fluid and easing swelling, and as a support for the kidneys and liver.

Punarnava is one of the most widely traded medicinal plants in India and appears in dozens of traditional multi-herb formulas, several of which are still dispensed in Indian hospitals today. Interest outside its traditional setting comes mainly from laboratory work on its distinctive root compounds, which appear to calm inflammation and shield kidney and liver tissue in animals.

This review examines what is known and not known about punarnava: what its active compounds do, which claimed effects rest on human evidence rather than animal work, what safety and product-quality questions surround it, and how it is dosed and monitored in practice.

View Review

Dendrobium is a large group of orchids whose thick, cane-like stems have been dried and brewed as a restorative tonic in East Asia for roughly two thousand years, where it is called shi hu. A few species, above all Dendrobium officinale and Dendrobium nobile, are now farmed at scale, and their stems reach buyers as tea, powder, and capsules.

The dried stem appears in the oldest Chinese herbal writings as a remedy for dryness, thirst, and a weak stomach, and it remains among the most costly plant materials sold in Chinese markets. Farming it has grown into an industry worth billions, which has drawn in both research funding and quality problems. A separate and much newer story runs alongside: in the 2010s, orchid extract began appearing in Western sports products sold for energy and focus, a use with no traditional precedent at all.

This review examines the two very different products that carry the Dendrobium name — the traditional stem preparation and the modern extract sold for stimulation — covering how each is thought to work, what human and animal studies report, where the evidence stops, and what is known about purity, dosing, and harm.

View Review

Massularia acuminata is a shrub of the West African rainforest whose stems have been cut into short sticks and chewed as a natural toothbrush for generations. The same stems, and the roots, are also boiled into drinks taken by men as a traditional strength and virility tonic. That double reputation — a cleaning tool for the mouth and a tonic for male vigour — is what draws attention to the plant today.

The plant is best known in southwestern Nigeria, where it is sold in markets as Pako Ijebu, and it is used across a belt of countries from Guinea to Cameroon. It reached Western shelves through bodybuilding products marketed as testosterone support, which is where most people outside West Africa first encounter it. Almost everything known about its effects, however, comes from animals rather than from people.

This review examines what the published evidence shows about Massularia acuminata: what its stems, roots and leaves contain, what has been measured in laboratory animals and in the mouth, what harms have been reported at higher doses, and how thin the human record is.

View Review

Pueraria mirifica, called white kwao krua in Thailand, is a tuberous forest vine whose root has been powdered and taken as a rejuvenating tonic for generations. It draws attention because that root carries plant compounds that switch on the same cell receptors as the body’s own estrogen, and the strongest of them are far more powerful than the plant estrogens found in soy.

Village use of the root for the discomforts of later life was written down in the 1930s, and the plant was later promoted as a Thai export crop. It is now sold worldwide, most visibly in products aimed at menopause relief and at breast enlargement. That same potency has drawn regulatory attention: Japan placed the plant on a watch list after buyers reported unexpected bleeding.

This review examines what controlled human studies, animal work, and post-market safety reporting show about what Pueraria mirifica does in the body, at what doses those effects appear, what harms have been recorded, and how reliably a given batch of root powder delivers what its label promises.

View Review

Danshen is the dried root of a red-flowered sage that grows across China and neighbouring regions. For two thousand years it has been used in Chinese herbal practice for problems involving the heart and circulation, and it is among the best-selling herbal products in Asia. Its appeal outside Asia rests on two families of active substances — one that dissolves in water, one that dissolves in oil — which together appear to relax blood vessels, quiet inflammation, and make platelets less prone to clumping.

The research base is unusually large in volume: thousands of trials have been run in China, most of them adding the root to standard heart medicines rather than replacing them, and a commercial drug-development programme has spent more than two decades seeking formal approval in the United States for a Danshen-based tablet for chest pain. The quality of that literature, however, varies widely, and a European trial of a plain water extract reported no benefit at all.

This review examines what the evidence shows about Danshen’s reported effects, the harms and drug interactions attached to it, the preparations and doses used in practice, and how far the strength of the underlying research supports any of it.

View Review

Pygeum is an extract of the bark of the African cherry tree (Prunus africana), an evergreen that grows in the mountain forests of sub-Saharan Africa. Southern African healers used bark preparations for urinary complaints long before European pharmacies took an interest, and since the late 1960s a standardized extract has been sold across Europe for men whose prostate has enlarged with age. The bark is rich in plant sterols and related fat-soluble compounds that appear to calm inflammation and slow the growth of prostate tissue.

Prostate enlargement is close to universal in ageing men, and the urinary consequences — a weak stream, incomplete emptying, and repeated trips to the bathroom at night — erode sleep long before they become a medical emergency. In France, pygeum was for decades the most-prescribed treatment for the condition, while regulators elsewhere never accepted the evidence behind it. Wild harvesting has also thinned the species, which now moves under international conservation controls.

This review examines what the human trial record, the laboratory work on the extract’s constituents, and the analyses of commercial products show about pygeum’s effects, its safety, how it is dosed, and where the evidence runs out.

View Review

Polygala tenuifolia (Yuan Zhi) is the dried root of a small perennial plant of northern China, Mongolia and Korea. Chinese physicians have used it for roughly two thousand years to settle the mind, ease restless sleep and sharpen recall, and it now appears in memory-focused supplement blends sold worldwide. Its root carries plant compounds that appear to raise a growth signal the brain uses to build and maintain the connections between nerve cells.

Attention outside its traditional setting grew when Korean researchers standardized a root extract and tested it in people, and when laboratory work suggested the root’s compounds help brain cells clear away misfolded protein debris. The same compounds that make the root active also irritate the throat and gut, which is why Chinese pharmacies have long boiled or baked the root with licorice or honey before dispensing it.

This review examines what is known about the root’s effects on memory, mood and sleep in humans, how those effects are thought to arise, where the evidence is thin or absent, and what the practical and safety trade-offs of sustained use look like.

View Review

Kava is a drink and supplement made from the root of a pepper-family shrub grown across the islands of the South Pacific. Communities in Vanuatu, Fiji, Samoa and Tonga have prepared it for centuries as a ceremonial and social beverage that calms the body without clouding thought, and it is now sold worldwide as capsules, tinctures and powdered root for tension and restless sleep.

Kava also sits at the center of an unresolved safety argument. In the early 2000s, reports of severe liver damage in Europe and North America led several governments to pull kava from the market; a German court later overturned that country’s ban, and the plant has remained legal in the United States throughout. Water-based preparations drunk daily across the Pacific have a very different track record from the solvent-based concentrates that were sold in Europe.

This review examines what human trials show about kava’s effects on tension, mood and sleep, what is known and disputed about liver damage and other harms, how plant variety and preparation method change both sides of that picture, and how the compound is used in practice.

View Review

Bitter orange (Citrus aurantium) is a citrus tree whose sour fruit, peel, and blossoms have been used for centuries in food, perfume, and traditional medicine. Modern supplements concentrate its main active compound, p-synephrine, and sell it for fat loss, appetite control, and workout energy. Commercial interest grew sharply after the stimulant herb ephedra was pulled from the market and sellers went looking for a legal replacement.

The plant leads an unusual double life. Its peel extract is the stimulant sold in fat-burner and pre-workout products, while its blossom oil, called neroli, is used in calming aromatherapy, and its juice behaves much like grapefruit juice around several common medicines. Human testing has been extensive but small in scale, and researchers remain openly divided over whether the extract is a mild metabolic tool for people optimizing body composition or a cardiovascular liability.

This review examines what controlled human research shows about bitter orange across its three forms: the durability of its metabolic effects, the separate evidence for the blossom oil, the blood pressure and heart rate signal, the medicine interactions, and how much of the published safety case comes from parties with a commercial stake in the answer.

View Review

Tart cherry is the fruit of a small tree grown mainly for pressing rather than for eating fresh, and almost all of the research uses a single variety, Montmorency. Because the raw fruit is too sour for most palates, it reaches people as juice, as a thick concentrate taken by the spoonful, or as a dried powder in capsules. The fruit is unusually rich in the deep red pigments that colour it, and it contains traces of melatonin. That combination is why an ordinary orchard crop has ended up both in athletes’ recovery routines and on bedside tables.

Interest in the fruit is older than the trials. A single physician’s report from 1950 described cherries easing joint attacks, and that account circulated for half a century before anyone tested it formally. Since the mid-2000s several dozen small studies have examined muscle recovery, sleep, and joint pain.

This review examines what those studies show, how solid the underlying evidence is, who funded it, and how the marketing claims compare with the data.

View Review

Kanna is a small succulent plant from the dry interior of southern Africa. For centuries the fermented plant was chewed to lift mood, settle nerves, and blunt hunger and thirst on long journeys. Modern interest centres on a family of plant compounds that act on the brain chemistry governing mood and calm, and on a standardised extract now sold worldwide as a capsule.

Written descriptions of the plant reach back to Dutch traders in the seventeenth century, and it remains one of southern Africa’s most valued traditional plants. Over the past two decades it has moved from a regional remedy to a global supplement, marketed for stress, focus, and social ease, and online interest in it has grown quickly. Nearly all of the human research so far has been carried out in healthy volunteers rather than in people seeking treatment.

This review examines what the human and laboratory evidence shows about kanna: how it appears to work, which benefits have actually been measured and on what strength of evidence, which harms and interactions have been reported, and how it is dosed, sourced, and monitored.

View Review

Dang Shen is the dried root of a bellflower relative that grows in the mountains of northern and western China. In Chinese medicine it sits in the group of roots used to restore energy, appetite and breathing capacity, and is widely called poor man’s ginseng, the affordable stand-in for true ginseng. Its main constituents are plant sugars and a set of small oily molecules that appear to work on immune cells and the gut lining rather than as a stimulant.

The root has been in continuous use for well over two centuries under its present name, and in late 2023 Chinese regulators added it to the national list of substances counted as both food and medicine, so it is now sold openly as a soup and tea ingredient as well as a remedy. Almost its entire clinical record, however, comes from multi-herb formulas rather than the root alone.

This review examines what is established about Dang Shen: the strength of the human evidence, the biology proposed to explain it, the preparations and amounts in use, the reported harms, and where its effects have never been measured at all.

View Review

Damiana leaf is the dried foliage of a small yellow-flowered shrub that grows across Mexico, the Caribbean and the far south of Texas. People have brewed it as a tea, taken it as a tincture and steeped it in liqueur for well over a century, most often with the promise of restoring sexual desire and lifting a flat mood. Supplement labels repeat those promises today, and the leaf now turns up inside dozens of blended products sold for libido, calm and weight control.

Interest persists partly because the leaf is chemically busy. It carries a large family of plant compounds, one of which is arbutin, and laboratory and animal work has tied these compounds to calmer behaviour, altered hormone handling and better blood-vessel signalling. Almost every human study, however, has tested damiana inside a multi-herb blend, so what the leaf on its own does in people has never been isolated.

This review examines what the available evidence shows about damiana leaf: where it comes from, how it may act in the body, which benefits and harms have actually been measured, how it is typically taken, and what remains unknown.

View Review

Jiaogulan (Gynostemma pentaphyllum) is a climbing vine of the cucumber family, native to the mountains of southern China and neighbouring parts of Asia, whose leaves are brewed as a mildly sweet tea. It attracts attention because it carries plant compounds that are chemically almost identical to those in ginseng, and because laboratory work ties its extracts to the cell’s main energy-sensing switch — the same switch that fasting and hard exercise engage.

In its home region the plant carries the folk name “herb of immortality”, attached to accounts of unusual old age among villagers in one mountainous province who drank the tea daily. Research has since moved well past that reputation: the leaf and its concentrated extracts have been tested in people for blood sugar handling, blood fats and body composition, and are now sold worldwide as loose tea, capsules and branded standardised extracts.

This review examines what the human evidence shows about jiaogulan — where controlled trials support an effect and how large it is, where the signal rests only on laboratory or animal work, what is known and unknown about its safety, and how it is dosed, sourced and monitored in practice.

View Review

Inulin-type fructans are chains of fructose sugars found in chicory root, onions, garlic, leeks, and Jerusalem artichoke. Human digestive enzymes cannot cut these chains, so they pass through the small intestine untouched and arrive in the large intestine, where resident bacteria ferment them. That single property — being food for gut microbes rather than for the person eating them — is why they are sold as prebiotic fiber and stirred into bars, yogurts, and drinks.

Chicory root has been roasted and drunk as a coffee substitute for centuries, but industrial extraction of its fiber began only in the 1980s. Since then these fructans have become both one of the most widely added fibers in the food supply and one of the most heavily trialled. A large share of that research has been paid for by the companies that manufacture the ingredient.

This review examines what controlled human trials show about inulin-type fructans across gut, metabolic, and bone outcomes, where the evidence is thin or contested, how tolerance limits intake, and what the reported harms look like.

View Review

Maral root is the underground part of a hardy mountain plant from southern Siberia, sold as a powder or concentrated extract. It is prized for one family of plant compounds it carries in unusually high amounts — insect-type steroids that plants make to deter grazing insects. In people these compounds do not act on the same target as testosterone, so the root is promoted as muscle and stamina support without the hormonal side effects of anabolic drugs.

Herders in the Altai and Sayan mountains used the root to restore strength after illness, and Soviet scientists studied it for decades as a tonic for soldiers and athletes. Much of that work was never published in English, so the plant reached Western shelves with a large reputation and a thin public record. Anti-doping authorities now track its main compound.

This review examines what is known about maral root: how its compounds are thought to work, what human and animal studies report for muscle, metabolism and ageing, which harms and product-quality problems have been documented, and how it is typically dosed and monitored.

View Review

Phellodendron amurense, the Amur cork tree, is a deciduous tree from northeastern Asia whose thick inner bark has been dried and used as a medicine for over a thousand years. The bark is rich in bitter yellow plant alkaloids — berberine chief among them — along with a family of citrus-like bitter compounds. Modern supplement makers sell it on its own and, more often, blended with magnolia bark or orange peel, marketing it for stress, joint comfort and weight control.

Interest outside Asia grew in two waves. Nutrition companies built branded blends around the bark in the early 2000s and tested them in small trials on stressed, overweight adults. Separately, a university cancer group spent more than a decade studying a standardized bark extract in the laboratory and, eventually, in men with prostate cancer. The two lines of work rarely reference each other, and neither has produced a large trial.

This review examines what the bark is, how its main compounds are thought to act, what human and laboratory studies report about its benefits and its harms, how it is dosed and sourced, and where the evidence is thin, contested, or drawn from products that contain other herbs alongside it.

View Review

Perilla (Perilla frutescens) is a leafy annual in the mint family grown across East Asia, where its seeds are pressed into a nutty cooking oil and its leaves are eaten fresh, pickled, or brewed as a tea. The seed oil stands out because roughly two-thirds of its fat is a plant form of omega-3 — a higher share than flaxseed or any other common edible oil. That single fact is why a culinary staple of Korea and Japan has drawn attention from people trying to rebalance a modern diet heavily weighted toward omega-6 fats.

Perilla has been cultivated for more than two thousand years, valued as much for its aroma and preservative qualities as for nutrition. Interest widened when Japanese researchers began comparing the oil with common seed oils in people who had breathing and allergy complaints, and when concentrates of the leaf were studied for hay fever.

This review examines what the evidence shows about perilla — the seed oil, the leaf, and their concentrated extracts — across benefits, risks, dosing, sourcing, and monitoring, and how firm that evidence is.

View Review

Maitake (Grifola frondosa) is a large, frilly mushroom that grows in overlapping clusters at the base of oak and other hardwood trees across Japan, China, and eastern North America. It is eaten as food and sold as a concentrated extract. Interest in it comes mainly from a family of fiber-like sugars in its cell walls that appear to interact with the cells of the immune system.

Japanese growers began cultivating maitake commercially in the 1980s, and Japanese laboratories then separated its extracts into named fractions that were studied for effects on immune cells, blood sugar, and tumors. Maitake is now among the most widely sold mushroom supplements outside Japan, yet the number of published human trials remains small, and several were run or funded by the companies that grow and sell the extracts.

This review examines what maitake is, how it is thought to act, what the human and animal evidence shows for its claimed benefits, what harms and interactions have been recorded, and how it is typically dosed, sourced, and monitored.

View Review

Hoodia is a group of spiny, leafless succulent plants from the deserts of southern Africa. The best-known of them, Hoodia gordonii, was chewed by San hunters to blunt hunger and thirst on long tracking trips. That practice turned the plant into one of the most heavily marketed natural appetite suppressants of the 2000s.

Interest grew after South African government chemists isolated a steroid-like sugar compound from the stems and patented it. A drug company and, later, a large consumer-goods company each licensed the compound, invested heavily, and then walked away. Meanwhile, products labelled Hoodia flooded the market, and repeated laboratory testing found that many contained little or none of the plant.

This review sets out what the published evidence shows: how Hoodia is thought to act on hunger signalling, what the human and animal studies actually measured, which side effects were recorded, and how product quality can be judged. It also examines who paid for the key studies and what that means for reading them.

View Review

Gymnema sylvestre is a woody climbing plant from the forests of India and Southeast Asia whose leaves have a striking property: holding them in the mouth briefly abolishes the ability to taste sweetness. Its Hindi name, gurmar, means “sugar destroyer”. The same leaves have been used for centuries to treat what traditional Indian medicine called “honey urine”.

Interest today rests on two related ideas. The first is behavioural: if sweet foods stop tasting sweet, people may eat fewer of them. The second is metabolic: leaf extracts have been studied for effects on blood sugar and other markers of metabolic health, and early Indian researchers reported that some people taking them were able to reduce their diabetes medication. Gymnema is now sold worldwide in capsules, powders and dissolving lozenges, and appears in many blood-sugar and weight-loss blends.

This review examines what the human evidence shows about gymnema’s effects on blood sugar, sweet-food intake and body weight; how it is thought to work; what harms have been reported, including rare liver injury; and what dosing and monitoring look like in practice.

View Review

Gelatin is what collagen becomes when the connective tissue of animals — skin, bone, tendon, hide — is partly broken apart by heat, acid, or alkali. The same material, broken down further so that it dissolves in cold water, is sold as collagen peptides. About half of it consists of three building blocks, glycine, proline and hydroxyproline, which the body uses to construct its own connective tissue and which most modern eating patterns supply sparingly.

People have eaten gelatin for centuries as broth, aspic and jellied desserts, and it remains one of the oldest ingredients in industrial food production. Attention from those focused on long-term health grew once powders made large daily amounts easy to consume, and once laboratory work on tendon, cartilage and skin raised the question of whether supplying these particular building blocks around physical loading changes how connective tissue is rebuilt.

This review examines what has been measured when gelatin is taken by mouth: which outcomes have been tested, how large and how reliable those findings are, what is given up by leaning on a protein that lacks one essential building block, and the practical matters of amount, timing, source and monitoring.

View Review

Black currant is a small, dark purple berry grown across northern Europe, Asia, and New Zealand. It carries a dense load of the deep pigments that colour dark berries, one of the highest vitamin C contents of any common fruit, and seeds yielding an oil rich in an uncommon omega-6 fat. The pigments appear to widen small blood vessels, which is why the berry now appears in capsules and sports drinks.

Britain grew the berry at national scale during the Second World War as a home-grown source of vitamin C once citrus imports stopped, and the syrup made from it was given to children. In the United States, planting the shrub was outlawed for decades because it hosts a fungus that kills white pine. Modern interest revived when New Zealand growers and sport scientists began testing standardised extracts.

This review examines the evidence on black currant in its main forms — whole berry, juice, standardised extract, and seed oil — covering exercise capacity, blood vessel function, and bone health, together with the safety questions, the gaps, and the places where the findings point in opposite directions.

View Review

Guggul is the sticky resin tapped from a small thorny tree that grows in the dry regions of India and Pakistan. Ayurvedic practitioners have used it for more than two thousand years, and it reached Western supplement shelves as a plant-based option for people who want to manage their blood fats without a prescription drug. The resin contains a family of plant steroids that appear to act on the liver machinery that converts cholesterol into bile.

Interest widened sharply once laboratory work identified a specific molecular target for those plant steroids. That discovery moved guggul from folk remedy into pharmacology journals, and marketers extended the claims well beyond blood fats, most prominently to thyroid activity and fat loss. Studies run in South Asia and studies run in Western countries have not told the same story, and the disagreement has never been resolved.

This review examines what the human and laboratory evidence shows about guggul: what it does to blood fats, what side effects and drug interactions it carries, how it is dosed, sourced and monitored, and where the evidence is thin, contradictory, or shaped by the interests of those who produced it.

View Review

Lemon verbena (Aloysia citrodora) is a lemon-scented shrub from South America whose dried leaves have been brewed as a calming, digestive tea for centuries. Modern interest centers on concentrated leaf extracts standardized for a polyphenol called verbascoside, which acts as an antioxidant and appears to influence how cells sense and use energy.

Spanish and Portuguese travelers carried the plant to Europe in the eighteenth century, where it became a garden herb and a perfumery oil. Over the past two decades, supplement makers have turned the leaf into purified extracts sold for sleep and calm, for exercise recovery, and — paired with hibiscus flower — for appetite and weight control. Each of those uses now has controlled human trial evidence behind it, though much of that evidence comes from the companies selling the ingredient.

This review examines what lemon verbena leaf extract does in humans: the size and consistency of its reported effects on sleep, body weight and recovery from hard exercise; the quality and funding of the studies behind those claims; the doses and standardizations used; what is known about its safety; and where the evidence remains thin.

View Review

Convolvulus pluricaulis is a small, sprawling, white-flowered herb of the morning-glory family that grows in the dry sandy soils of the Indian subcontinent. In Ayurveda it sits in the group of plants used to sharpen intellect and steady the mind, and it is sold today as a dried powder, a syrup, a tablet or a concentrated extract marketed for memory, calm and sleep. Its appeal to people managing their own long-term brain health is obvious: an inexpensive, widely available plant with a long record of human use and a plausible effect on the chemistry of learning.

Indian medical texts have described the plant for roughly two thousand years. Four botanically unrelated species still circulate in Indian markets under the same vernacular name, so what reaches a buyer is not always what the label claims. Laboratory and animal work on the plant is extensive; controlled work in people is almost absent, and the gap between those two bodies of evidence is the central question here.

This review examines what is known about the plant’s effects, how strong the evidence behind each claim is, where the risks and drug interactions lie, and how the material is dosed, sourced and monitored.

View Review

Guduchi is a climbing shrub native to India whose stem has been used in Ayurvedic medicine for well over two thousand years. Its Sanskrit name, amrita, translates as nectar of immortality. Modern interest centres on a single unusual claim: that the same plant can strengthen a weak immune response and calm an overactive one.

For most of that history it was taken for fever, jaundice and joint pain. During the coronavirus pandemic it became one of the most widely consumed herbal products in India, after national health authorities named it in public advisories. The surge in use was followed by hospital reports of liver inflammation in people taking it, and by an unresolved argument over whether the authentic plant, a look-alike species, or contaminated products were responsible.

This review examines what controlled human studies, laboratory work and clinical safety reporting show about Guduchi: which effects have been measured, how large they are, where the record is thin or contested, and what the liver findings mean for adults weighing sustained use as part of a health and longevity strategy.

View Review

Peppermint (Mentha × piperita) is a hybrid of watermint and spearmint whose leaves and concentrated oil have been used as a digestive remedy and a flavouring for centuries. Its main active ingredient, menthol, relaxes the muscle layer of the gut wall and switches on the nerve endings that register cold, which is why the plant draws interest well beyond the confectionery aisle.

Capsules of peppermint oil are among the most widely used non-prescription treatments for irritable bowel syndrome, and the plant also appears in preparations for indigestion and in solutions dabbed on the forehead for headache. Its standing is contested. Pooled analyses of older trials look favourable, while several of the more recent and more tightly controlled studies could not separate peppermint oil from a dummy treatment.

This review examines what the evidence shows about peppermint and peppermint oil: the outcomes they have and have not been shown to change, the doses and preparations used, the harms reported, and the quality and funding of the research behind those claims.

View Review

Baikal skullcap (Scutellaria baicalensis) is a flowering plant of the mint family whose bright yellow root has been dried and used as a medicine across East Asia for well over a thousand years. The root is unusually rich in a small family of yellow plant pigments, and current interest centres on their combined anti-inflammatory and antioxidant activity.

In classical Chinese practice the root was a cooling remedy for fevers, coughs, and digestive complaints, and it remains one of the most frequently prescribed herbs in that tradition. In the West it reached pharmacy shelves mainly inside joint-comfort products, where a standardised root extract is paired with an extract of the cutch tree. That pairing later drew regulatory attention after reports of liver problems.

This review examines what controlled human research shows about the root and its purified compounds: where the case for benefit is strongest, where it thins into animal and laboratory work only, and how the liver and lung safety signals reported for skullcap-containing products sit alongside those benefits.

View Review

Weeping forsythia is a yellow-flowered shrub whose dried fruit has been used as a medicine in China, Japan and Korea for roughly two thousand years. The fruit is among the most heavily used plant materials in East Asian herbal practice and is a core ingredient in several well-known preparations taken at the first sign of a cold or fever. Interest beyond that tradition grew once laboratory work isolated a small group of compounds in the fruit that quiet inflammatory signalling and interfere with viruses.

The fruit is picked at two stages of ripeness, and the two grades differ enough in chemistry that products are not interchangeable. Almost all human testing has used multi-herb preparations rather than the fruit alone, and much of it was funded or run by the company that makes the leading branded formula. A single purified compound from the fruit has recently completed first-stage human safety testing.

This review examines weeping forsythia: how it is thought to work, what the human and animal evidence shows for benefit and harm, how it is dosed, sourced and monitored, and where the evidence base is thin, contested or shaped by the interests of those who produced it.

View Review

Vitexin is a plant compound found in mung bean seed coats, hawthorn berries, passionflower, pearl millet, bamboo leaves, and fenugreek seeds. It belongs to the flavonoid family, the same broad group of colorful plant chemicals found in berries and tea. Chemically it is apigenin with a sugar locked onto it, and that sugar makes it far more water-soluble and far harder for the gut to absorb.

People have eaten vitexin-rich plants for thousands of years, and several of them are long-standing herbal remedies — hawthorn for the heart in Europe, passionflower for restlessness. The isolated compound is newer. Most of what is claimed for it comes from laboratory dishes and rodents. A second, older thread of research runs the other way: heavy reliance on pearl millet in regions with little dietary iodine has been linked to enlarged thyroid glands, and vitexin is among the compounds under suspicion.

This review examines vitexin as a purchased, concentrated ingredient rather than as part of a whole plant: how much of a swallowed dose reaches the bloodstream, which effects have been measured in living animals and in people, which harms have been recorded, and where the evidence simply runs out.

View Review

Cnidium monnieri is a flowering plant of the carrot family whose dried fruits have served as a medicine across East Asia for roughly two thousand years. Most of its activity is credited to a group of plant compounds called coumarins, above all one named osthole, which relaxes smooth muscle and shifts the balance between bone building and bone breakdown. It reaches Western buyers mostly as a capsule or standardized extract sold for male sexual function, and inside topical creams and washes for itchy skin.

Classical Chinese texts list the dried fruit chiefly for skin complaints and for weakness of the reproductive system, applied as a wash at least as often as it was swallowed. Laboratories have since taken the plant apart in detail, yet the enthusiasm that followed rests almost entirely on cell and animal work rather than on studies in people.

This review examines what is actually established: the biology behind the claims, how strong the evidence is for each proposed effect, the safety questions raised by the plant’s light-sensitising compounds and its effects on liver enzymes, and the practical matters of dose, form, and product quality.

View Review

Clubmoss is the common name for a family of small, ancient, moss-like plants that spread across forest floors long before flowering plants existed. One of them, the Chinese clubmoss, concentrates a compound called huperzine A that slows the breakdown of a signaling chemical the brain uses for memory and attention. Most supplements sold as clubmoss are in fact standardized extracts, or the purified compound itself.

Chinese herbal practice used the plant for centuries for bruising, swelling, fever and muddled thinking. Chinese regulators licensed the purified compound as a prescription medicine for memory loss in the 1990s; almost everywhere else the same substance sits on shelves as an unregulated supplement. Laboratory testing of those products has repeatedly found contents that do not match the label.

This review examines what clubmoss is, what controlled human research shows about memory and thinking, what its action on the nervous system means for the rest of the body, how it is dosed, cycled and sourced, and where the evidence remains thin.

View Review

Goji berries, also sold as wolfberries, are the small red fruits of two closely related shrubs grown mainly in northern China. They are eaten dried, brewed as tea, pressed into juice, or sold as a concentrated extract. Interest in them comes from an unusual composition: they are one of the richest food sources of a yellow pigment the eye stores in the central patch of retina used for sharp vision, and they carry complex sugars that gut bacteria ferment.

The dried fruit has been used in China for roughly two thousand years, described in old texts as a tonic for the eyes and liver and as a food for a long life. From the early 2000s it was rebranded in Western markets as a premium health food, with selling claims well ahead of the human data. Controlled feeding studies have since been run in middle-aged and older adults, and a modest daily portion is enough to measurably change blood pigment levels.

This review examines what those studies show for eye, metabolic and immune measures, how large the changes are, where the human evidence is thin or came from companies selling the product, and what the safety record shows.

View Review

Passionflower is a climbing vine native to the Americas whose dried leaves, stems and flowers have been brewed as a calming tea for centuries. It is sold today as a capsule, a liquid extract and a tea, usually for nervous tension, restlessness and trouble sleeping. The interest in it rests on a simple proposition: that a plant might quiet an over-active nervous system without the next-day dullness, memory gaps and dependence that follow the sedative drugs used for the same complaints.

The plant entered European and North American medicine in the nineteenth century and remains registered across Europe as a traditional herbal medicine, while in the United States it is sold as a dietary supplement. Attention has since widened from calm and sleep toward whether it can help people step down from long-term sedative use.

This review examines what the human evidence shows: where passionflower has been tested, what those trials measured, how large and how consistent the results were, what is known about its safety and its behavior alongside other calming substances, and how much confidence the quality of commercial products permits.

View Review

Lemon balm (Melissa officinalis) is a lemon-scented member of the mint family, grown across Europe and western Asia and taken as a tea, a tincture, a capsule, an inhaled oil, or a skin cream. Its leaves are rich in plant acids and aromatic oils that appear to act on the brain’s calming chemistry, which is why it is sold today for stress, restlessness and disturbed sleep.

The plant has one of the longest documented histories in Western herbal medicine, appearing in Greek and Roman texts more than two thousand years ago and later prized by monastic physicians as a remedy for low mood and heart flutter. Modern interest revived when laboratory work identified a specific target for that traditional calming reputation, and when small clinical studies began reporting changes not only in mood and sleep but also in blood fats and blood pressure.

This review examines what the current human evidence shows about lemon balm across mood, sleep and heart-and-metabolism measures, how large and how dependable those changes are, what is known about its safety, interactions and long-term use, and where the evidence remains thin, contested, or funded by parties who sell the extract.

View Review

Feverfew (Tanacetum parthenium) is a small, aromatic, daisy-like plant of the aster family that has grown in European gardens for centuries and served as a household remedy for far longer. Its dried leaves, and concentrated extracts made from them, are sold today mainly to make migraine attacks less frequent. Attention centres on a bitter compound in the leaf, parthenolide, which dampens the inflammatory signalling that runs inside cells.

The plant’s English name descends from a Latin word meaning to drive out fever, and older herbal practice used it for fevers, aches, and difficult childbirth. Its modern reputation began in Britain in the 1970s, when people with migraine who chewed the fresh leaves reported fewer attacks and hospital doctors decided to test the claim properly. The same leaf compound has since been pursued as a starting point for anti-inflammatory and anti-cancer drugs.

This review examines what the human and laboratory record shows: how feverfew is thought to act, which effects hold up and which remain unsettled, what harms have been documented, how preparations differ, and how it is used in practice.

View Review

Eucommia bark is the dried bark of a Chinese tree, Eucommia ulmoides, taken as a strengthening tonic for roughly two thousand years and still among the most heavily traded items in the Chinese herbal supply. A piece snapped apart trails fine white elastic threads across the break — a natural rubber that gives the tree its other name, the hardy rubber tree. Modern interest rests on a small group of compounds in the bark that relax blood vessels and act on bone-building cells.

A roasted-leaf tea from the same tree became an everyday drink in Japan in the 1970s, and the bark itself is sold worldwide as a capsule, powder, or tea, usually marketed for blood pressure, joints, and back strength. Laboratory and animal work on it is extensive. Controlled testing in people is not, and the little that exists is short and unreplicated.

This review examines what the bark contains, what the human and animal evidence shows for blood pressure, bone, and body composition, where the safety signals lie, and how the material is dosed, sourced, and monitored.

View Review

Horse chestnut (Aesculus hippocastanum) is a large ornamental tree whose seeds have been processed into medicinal extracts in Europe for more than a century. Modern preparations are standardized to escin, the plant compound that carries most of the activity. Interest centers on the leg veins: escin appears to tighten vein walls and slow the leakage of fluid out of the smallest blood vessels into surrounding tissue, the process that produces swollen, aching, heavy legs.

Failing leg veins are among the most common chronic conditions in adults, and how often they occur climbs steadily with age. In Germany and much of continental Europe, standardized horse chestnut seed extract has been a licensed medicine for decades and is used alongside elastic compression stockings; in the United States the same material is sold only as a dietary supplement. Raw seeds, bark, and leaves are a separate matter — they contain a toxin and have caused poisonings.

This review examines the outcomes horse chestnut extract has been tested against, how large and how reliable those outcomes are, its safety record, how it compares with compression and with other vein-active preparations, and the practical questions of dose, formulation, sourcing, and monitoring.

View Review

Stephania tetrandra is a climbing vine from southern China whose thick root, called han fang ji, has been used for centuries to relieve swelling, joint pain and difficult urination. Its most studied ingredient is tetrandrine, a plant compound that slows the entry of calcium into cells and damps down inflammation. The root has drawn attention outside Asia because that same compound keeps reappearing in modern laboratory screens for very different diseases.

In China the purified compound has been a licensed treatment for dust-related lung scarring for decades, which makes it one of very few plant medicines to reach that standing anywhere. The root also carries an unusual burden. A different and unrelated plant, sold under a confusingly similar Chinese name, caused an outbreak of kidney failure and urinary tract cancer in Europe in the 1990s, and the two roots are still mixed up in trade today.

This review examines what human and laboratory work actually shows about the root and its main compound: where effects have been measured in people, where the case rests on animal work alone, and how the hazards, including the mix-up problem, sit alongside the reported gains.

View Review

Japanese honeysuckle (Lonicera japonica) is a climbing vine whose dried flower buds have been brewed as a tea and used as a medicine across East Asia for over a thousand years. The buds are unusually rich in plant acids and flavonoids, the same families of compounds found in coffee and dark-colored vegetables, and laboratory work has focused on how these compounds affect inflammation and viruses.

The plant sits at an unusual crossroads. In China it is classified as both a food and a medicine, sold as a cooling summer drink and included in some of the most widely dispensed herbal cold and flu preparations. It has also drawn attention from a different direction: reports that a small genetic fragment carried in the flower survives brewing, enters the bloodstream and acts on infecting viruses, a claim that remains disputed between research groups.

This review examines what is known about Japanese honeysuckle as a health and longevity intervention: how its main compounds behave once swallowed, which effects rest on human data and which rest only on laboratory or animal work, what harms and quality problems have been documented, and how the herb is prepared and dosed in practice.

View Review

Celastrus paniculatus (also called Jyotishmati, Malkangni, or the intellect tree) is a woody climbing vine of the Indian subcontinent whose oily seeds have been taken for centuries as a brain tonic. Interest today centres on its reputation for sharpening memory and steadying mood, and on laboratory work suggesting the seed oil shields nerve cells from damage.

Classical Indian medical texts group the seeds among preparations meant to preserve mental clarity into old age, and the plant has since moved from that setting into the supplement market as a powder, capsule, or pressed oil. Almost everything measured so far, however, comes from animals and cell cultures rather than from people, and the vine is becoming scarce across parts of its native range.

This review examines what the available evidence shows about Celastrus paniculatus seeds and seed oil: how they are thought to act, which effects have been observed and in which species, what harms and contamination concerns have been documented, and how the preparations are dosed, sourced, and monitored in practice.

View Review

Griffonia simplicifolia is a woody climbing shrub of the West African forest belt whose black seeds are unusually rich in 5-hydroxytryptophan, or 5-HTP — the molecule the body converts in a single step into serotonin. Because serotonin helps set mood, appetite and the timing of sleep, seed extracts have become one of the most widely sold plant-derived supplements aimed at those three targets.

In West Africa the plant was long used for chewing sticks, animal fodder and as an insecticide, and it entered world trade only after the serotonin pathway was mapped in the mid-twentieth century. Ghana alone has exported thousands of tonnes of seed, and China is now the main buyer and processor. Views on the extract range from treating it as a gentle plant alternative to prescription mood medication to dismissing it as a leftover of an older, contested model of low mood.

This review examines what controlled human research shows about Griffonia simplicifolia and the 5-HTP it supplies: which effects have been measured, how large those effects are, what the safety record actually contains, and where the evidence remains thin or contested.

View Review

Chaste tree is a Mediterranean shrub whose small, peppercorn-like dried fruit has been used as a medicine for more than two thousand years. Modern extracts of the fruit act on the hormone-control center at the base of the brain, where they dampen release of the milk-producing hormone prolactin. Because that hormone also shapes the monthly cycle, the plant has become a mainstay of women’s herbal medicine.

European physicians have prescribed standardized chaste tree preparations since the middle of the last century, and it remains one of the few plant medicines licensed as a regulated medicine in Germany for cycle-related complaints. Premenstrual symptoms, tender breasts, and irregular cycles are common enough that many adults look for an option that is neither hormonal contraception nor an antidepressant.

This review examines what the clinical evidence shows about chaste tree: how it is thought to work, which effects hold up and which do not, the risks and interactions that follow from its hormonal action, how it is dosed and monitored, and how sound the underlying research is.

View Review

Black cohosh is a woodland plant from eastern North America whose thick underground stem and roots have been used as a medicine for centuries. Standardized root extracts are now among the best-selling plant products taken for the changes that arrive as menstrual cycles end — hot flashes, night sweats, broken sleep, and shifting mood. Their appeal rests on a simple promise: relief without adding hormones — a trade-off that matters to anyone weighing long-term risk as carefully as short-term comfort.

Indigenous peoples of the Appalachian region used the root for pain, childbirth, and menstrual trouble long before European settlers took it up. Twentieth-century German manufacturers standardized it and carried it into pharmacies worldwide. Its standing has been contested for as long as it has been studied: some trials report clear symptom relief, others find it no better than a placebo, and scattered reports of liver injury have prompted warning labels in several countries.

This review examines what human research shows about black cohosh: how it may work, which benefits and harms have been measured and how firmly, how it is dosed, sourced, and monitored, and how the funding behind the studies shapes what the evidence can support.

View Review

Panax quinquefolius is a slow-growing woodland root native to eastern North America. Indigenous peoples of the eastern woodlands used it as a general tonic centuries before it became one of the continent’s earliest export goods. It is a close relative of Asian ginseng, but it carries a different mix of the plant compounds called ginsenosides, and it is usually described as milder and less stimulating than its Asian cousin.

Today the root is farmed on a large scale in Wisconsin and Ontario, and most of the harvest is shipped to Asia. Attention as a health supplement has settled on three uses: steadying blood sugar after meals, easing the deep tiredness that follows cancer treatment, and sharpening short-term memory. Much of what is sold at retail rests on far thinner ground than those three.

This review examines what controlled human trials show about Panax quinquefolius, where those findings disagree with one another, how much of the research was paid for by the firms that sell the root, and what the practical questions of dose, product quality, and drug interaction look like.

View Review

Caralluma fimbriata is a small, edible succulent that grows wild across the drier parts of India, where villagers have long eaten it boiled, pickled, or raw. Tribal hunters are said to have chewed the stems to hold off hunger and thirst on long treks. Since the early 2000s a concentrated extract of the plant has been sold worldwide in capsule form as a natural appetite suppressant and weight-management aid.

The plant’s appeal rests on a simple idea: that something people have eaten as food for generations might blunt hunger without the cost, prescription requirement, or side-effect burden of modern weight-loss medicines. United States regulators have accepted one branded extract as safe for use in food, while European authorities declined to approve the marketing claims made for it. That split has left the plant widely available but unevenly judged.

This review examines what controlled human trials, pooled analyses, animal work, and safety testing actually show about Caralluma fimbriata — where the signals are real, where they are absent, where they conflict, and how much of the published record comes from parties who sell the extract.

View Review

Thunder god vine (Tripterygium wilfordii) is a climbing shrub from southern China whose peeled root has been used in Chinese medicine for centuries to calm swollen, painful joints. The root carries two unusually forceful molecules, triptolide and celastrol, that damp down inflammatory signalling far more powerfully than most plant extracts.

Chinese hospitals have prescribed standardised root preparations for joint and kidney disease since the 1960s, and Western trials followed. The same potency casts a shadow: the plant is toxic enough to have earned a Chinese nickname about dying within a few steps, and its bark, leaves and flowers have caused fatal poisonings. Interest from the longevity field arrived by a separate route, after laboratory work suggested that celastrol restores the body’s sensitivity to the hormone that signals fullness.

This review examines what the human and laboratory evidence shows about thunder god vine’s effects, how large and how reliable those effects are, the harms recorded alongside them, and how the preparations tested in trials differ from what is sold as a supplement.

View Review

Green oat extract is a concentrated preparation made from the oat plant while it is still green and flowering, weeks before the grain ripens. It is a different material from breakfast oats: the soluble fibre that lowers cholesterol is largely absent, and what is concentrated instead is a mixture of plant compounds that laboratory work links to the brain’s chemical messengers. Products are sold as a caffeine-free way to sharpen attention and mental stamina.

The plant has a long record in European herbal practice as a restorative for exhausted nerves, and a nineteenth-century tincture was once given to people trying to give up tobacco. Modern interest restarted when a screened oat variety turned out, in test-tube work, to slow an enzyme that breaks down dopamine, the messenger tied to focus and drive. Since 2011 a handful of controlled trials in middle-aged and older adults have tested that idea directly.

This review examines what those trials, the supporting laboratory work, and the safety record show about green oat extract, where the findings disagree, and who funded them.

View Review

California poppy (Eschscholzia californica) is the bright orange wildflower of the western United States and Mexico. Its dried flowering tops are sold as a tea, liquid extract, or tablet for mild calming use. Despite the shared family name, the plant carries none of the opium-type compounds of its better-known relative; its own plant compounds appear instead to act on the calming side of the nervous system.

Indigenous peoples of California used the plant for pain and restlessness, and European makers of plant medicines have sold it for disturbed sleep for over a century. European regulators list it as a traditional remedy for mild mental strain and as a sleep aid, a status granted on long use rather than modern trial data. It is rarely sold alone; most products pair it with valerian, hawthorn, or passionflower.

This review examines how California poppy’s compounds are thought to act, what human studies of sleep, tension, and pain measured, how much of that work tests the plant alone rather than a mixture, what safety signals exist including effects on the liver’s drug-processing machinery, and how far commercial preparations differ in strength.

View Review

Neem is an evergreen tree native to the Indian subcontinent whose leaves, bark, seeds and seed oil have been used as medicine for well over two thousand years. Its extracts contain a family of intensely bitter plant compounds that kill or disable bacteria, fungi and insects and that quiet inflammatory signalling inside cells. Modern interest turns on a single question: whether that broad antimicrobial and anti-inflammatory action translates into measurable health effects in people.

Neem is already in daily use worldwide. Chewing sticks cut from its twigs are a standard tooth-cleaning tool across South Asia, Africa and the Middle East, and neem toothpastes, mouthwashes, soaps, oils and leaf capsules sell in most markets. Alongside that everyday familiarity sits a long-recorded pattern of severe poisoning when neem seed oil is swallowed by infants, and a large body of animal work showing that concentrated seed preparations block fertility.

This review examines what controlled human research shows about neem across its main uses, how strong that evidence is, where the safety limits lie, and which preparations, doses and routes of use the human data actually cover.

View Review

Kutki is the dried root and rhizome of a small Himalayan plant (Picrorhiza kurroa) that grows on rocky slopes at roughly 3,000 to 5,000 metres. The root is intensely bitter, and that bitterness comes from a family of compounds that laboratory work has repeatedly linked to protection of liver tissue. In Ayurveda the root has been used for centuries for jaundice, fevers and breathing complaints, and it now turns up in a large share of commercial liver-support formulas sold worldwide.

The plant itself is scarce. Decades of wild digging pushed it onto international protected-species lists, and the Indian government now subsidises its cultivation. Research attention has also shifted: from kutki as a jaundice remedy toward kutki as a candidate for fatty liver, a condition tied closely to metabolic health and common in adults who otherwise feel well.

This review examines what is actually known about kutki — how it is thought to work, what the human and animal records show, where the evidence is thin or openly contested, what risks the herb and its supply chain carry, and how it is dosed, sourced and monitored in practice.

View Review

Gou-teng is the hooked stem of a climbing vine, Uncaria rhynchophylla, that has been used in Chinese herbal practice for roughly fifteen centuries. It is the herb Chinese and Japanese practitioners reach for when the presenting picture is agitation, dizziness, tremor, high blood pressure, or convulsions — a cluster traditionally described as internal wind. Its interest to modern researchers rests on a group of plant compounds that relax blood vessels and act on brain receptors governing arousal and aggression.

The herb rarely travels alone. It is the defining ingredient of three widely dispensed formulas: one prescribed across East Asia for high blood pressure, and two that Japanese physicians prescribe under national health insurance for the irritability, hallucinations, and aggression that accompany dementia. That prescribing base has produced placebo-controlled trials and adverse-event registries that most single herbs never accumulate, though almost all of them test the formula rather than the herb by itself.

This review examines what is known about Gou-teng: how its constituents act, what controlled human studies of its formulas have measured, what harms have been recorded, how it is dosed and sourced, and where the evidence stops short of the claims made for it.

View Review

Thai ginseng is the dark purple underground stem of a plant from the cool uplands of Thailand, Laos and Myanmar. Despite the name it is not a ginseng but a close relative of common ginger, and Thai villagers know it as black ginger. It has drawn attention because a handful of unusual plant compounds in the root appear to act on blood vessels and on the way the body burns fuel.

For generations the root was sliced and steeped in rice liquor as a working man’s tonic for stamina, digestion and sexual vigor, which is how it earned its regional reputation as a plant-based alternative to prescription treatments for erectile difficulty. Over the past two decades Japanese and Korean food companies have turned it into measured capsules and marketed it for abdominal fat and exercise capacity, and it now turns up in sports blends and men’s health formulas worldwide.

This review examines what controlled human studies show about the root across body composition, physical performance and sexual function, how it is thought to work, what is known about its safety and its behavior alongside medicines, and how much weight the evidence can carry given who funded it.

View Review

Tetraselmis chuii is a single-celled green marine alga, grown in seawater tanks and dried into a dark green powder. It is sold as a food supplement because the cells are unusually rich in the enzymes living tissue uses to defend itself against oxygen damage. Interest centers on the idea that eating this biomass nudges the body’s own protective machinery rather than simply adding another antioxidant to the diet.

The alga has been farmed for decades as feed for shellfish and fish hatcheries. European regulators cleared it for human food in 2014 and for supplement use in 2017, and a handful of small human studies followed, mostly in athletes and in men attending fertility clinics. Almost all of that work involves the company that produces the ingredient.

This review examines what the published evidence shows about Tetraselmis chuii: which effects have been measured in people, how large and how reliable those measurements are, what is known about safety and product quality, and where the claims still rest on cell and animal work alone.

View Review

Olive extract is a concentrated preparation made from the leaves or fruit of the olive tree, and it is not the same thing as olive oil. Its signature compounds — oleuropein and hydroxytyrosol — are present in olive leaves at far higher levels than in the oil pressed from the fruit. Interest in these compounds grew out of a simple observation: populations eating a traditional Mediterranean diet tend to have less heart disease.

Olive leaves have a long recorded history of use, from bitter teas brewed for fevers in the nineteenth century to today’s standardized capsules sold worldwide. Modern attention has centered on blood pressure, cholesterol, and blood sugar, and several trials have compared olive leaf preparations directly against standard medicines. Views differ on how much of the benefit survives careful testing, and on whether leaf, fruit, and oil preparations should be treated as one intervention or as several distinct ones.

This review examines what the human evidence shows about olive extract: which effects are supported, how large they appear, where findings conflict, what the safety record looks like, and how the preparations differ in strength and quality.

View Review

Crocins are the water-soluble red-orange pigments that give saffron its color, and they are also found in the fruit of the gardenia plant. Unlike most plant pigments, they dissolve readily in water, which makes them straightforward to press into a tablet and to measure precisely. They are now sold on their own, separately from whole saffron extract, and are studied mainly as a way to calm inflammation and to protect nerve and eye tissue.

Saffron has been used as food, dye, and folk remedy for thousands of years, and it remains the most expensive spice by weight. Modern chemistry separated its individual pigments, and researchers then began testing the isolated pigment in people rather than the whole spice. Human trials have since been run mostly in small groups and mostly from a handful of research centers.

This review examines what the human evidence shows about isolated crocins: where effects have been measured and repeated, where they rest on a single small study or on animal work alone, how much of an oral dose actually reaches the bloodstream, and what the safety record looks like.

View Review

Broccoli seed is the ungerminated seed of the broccoli plant, and it is the most concentrated natural store of glucoraphanin, the inactive form of sulforaphane. Sulforaphane switches on a cellular defense system that raises the body’s own antioxidant and toxin-clearing enzymes. Seeds hold far more of the stored form than mature florets do, which is why they are the starting material for most concentrated broccoli supplements and for the sprouts people grow at home.

Interest grew after laboratory work in the early 1990s traced much of broccoli’s reputation to this single molecule and then showed that seeds and young sprouts contain many times the amount found in the vegetable. Attention has since moved from eating broccoli to standardized seed preparations, partly because cooking destroys the enzyme that makes the conversion possible, and partly because a capsule is easier than a kitchen full of sprouting jars.

This review examines what broccoli seed and its extracts do in people: which effects rest on controlled human trials and which on laboratory work, how much active material different preparations actually deliver, what side effects and drug interactions have been recorded, and how whole seeds, sprouts, and standardized capsules differ in practice.

View Review

Shiitake (Lentinula edodes) is an edible mushroom native to East Asia and the second most widely cultivated mushroom in the world. Beyond its savory flavor, it is unusual among common foods for the compounds packed into its cell walls: a family of long-chain sugars that interact directly with receptors on immune cells, plus a sulfur-containing antioxidant that the human body actively transports into tissues. That combination has made shiitake a fixture of both the kitchen and the medicine cabinet.

Chinese and Japanese texts have described shiitake as a strengthening food for close to a thousand years. In the late 1960s, Japanese researchers isolated one of its cell-wall sugars, and a purified injectable form was later approved in Japan as an add-on to cancer chemotherapy. Modern interest has since widened to immune resilience, cholesterol, and the vitamin D that shiitake produces when exposed to sunlight.

This review examines what the human evidence shows about eating shiitake and about taking the concentrated extracts made from it: which effects hold up, how large they are, where findings disagree, what harms have been documented, and what a practical protocol looks like.

View Review

Butea monosperma is a flowering tree native to the Indian subcontinent, known locally as palash and in English as the flame of the forest for its vivid orange blossoms. Its flowers, bark, seeds, and gum have long been used in traditional Indian medicine. Modern interest rests on its chemistry: the flowers are among the richest natural sources of butein, an orange plant pigment, while the bark carries a separate family of molecules that act on bone-building cells.

The tree appears in classical Indian medical writing, and preparations of its different parts remain in everyday use across South Asia. Laboratory and animal research over the past two decades has followed a narrower thread than the traditional record — whether the bark molecules can slow the bone loss that follows menopause, and whether butein changes how long simple laboratory organisms live and how well they withstand stress.

This review examines what the evidence shows for Butea monosperma: which of its compounds are active and by what route, what the research supports and where it runs out, what harms the different parts of the plant carry, and how the preparations sold today differ from one another.

View Review

Kiwi is the berry of a climbing vine native to China, sold as the fuzzy green Hayward fruit or the smooth golden SunGold. Two of them carry more vitamin C than most people get from a full day of eating, plus soft fibre that holds water and a natural protein-splitting enzyme. That combination has turned an ordinary supermarket fruit into something tested in formal trials rather than merely recommended.

Grown commercially only since the mid-twentieth century, kiwi moved from garden curiosity to export crop, then to research subject once clinicians noticed that people eating it daily reported easier bowel movements. It has since been compared head-to-head with standard fibre supplements, and its effect on sleep has been examined in controlled settings. Much of that work was paid for by the industry that sells the fruit.

This review examines what those trials show about eating kiwi as a deliberate daily practice rather than as an occasional food: which effects hold up, how large they are, where the allergy and digestive risks sit, and how heavily the evidence leans on funders with an interest in the answer.

View Review

Butcher’s broom is a low, spiny evergreen shrub of the Mediterranean; the part used in medicine is the underground stem and root. Extracts are swallowed as capsules or drops by people whose legs feel heavy and swollen by day’s end. What sets it apart from most plant remedies is how it acts: rather than working mainly as an antioxidant, it tightens vein walls directly, so less blood and fluid settle in the lower limbs.

Weak, leaky leg veins are among the most common long-term conditions in adults, and they grow more frequent with every decade of life. In several European countries a standardised butcher’s broom preparation has been sold as a licensed medicine for more than fifty years, and pooled trial results have been used to support formal treatment guidelines. Much of that trial evidence, though, was produced by or for the company that sells the leading product.

This review examines what human trials show about butcher’s broom for leg symptoms, swelling and related circulatory complaints, how it is thought to work, what harms have been recorded, how it is dosed and tracked, and where the evidence is thin or commercially entangled.

View Review

Black garlic extract is made from ordinary garlic bulbs held for weeks at controlled warmth and humidity until the cloves turn dark, soft, and sweet. The heat shuts down the enzyme that produces garlic’s sharp bite and converts the pungent sulfur compounds of the raw bulb into milder, water-soluble ones that survive digestion well. The result is a garlic preparation that can be taken daily without the breath, the stomach burn, and the social cost that stop many people from using raw garlic at all.

Aged garlic preparations have been used in East Asia for well over a century, but the black garlic sold today dates only to the early 2000s, and standardized capsules are newer still. Interest from the longevity field rests on a simple observation: the compounds that build up during aging are the ones most closely tied to blood pressure, cholesterol handling, and the body’s own antioxidant defenses.

This review examines what controlled human research shows about black garlic extract — where findings are firm, where they lean on the wider garlic literature rather than on black garlic itself, which risks and interactions have been documented, and how the extract is dosed, sourced, and monitored.

View Review

Mulberry fruit extract is a concentrated preparation made from the berries of the mulberry tree (Morus alba and closely related species), the same tree whose leaves feed silkworms. Ripe mulberries are dark, sweet, and unusually rich in two very different things: the purple pigments that give the fruit its color, and a small sugar-shaped molecule that blocks one of the gut enzymes that break starch down into blood sugar. That second ingredient is why a berry is sold as a blood sugar supplement at all.

Mulberries have been eaten fresh and used as a restorative tonic across China, Korea, Turkey, Iran, and India for centuries, and the tree has been farmed for silk far longer. Attention from outside that tradition grew once food scientists found that a measured dose of the fruit extract, stirred into a plate of rice, changed how fast that meal reached the bloodstream. Most human testing since has come from one corporate research program.

This review examines what the extract does in people, how large and durable those changes are, what they cost in comfort and money, and where the evidence is thin or produced by parties with something to sell.

View Review

Garcinia cambogia is a small, pumpkin-shaped tropical fruit whose dried rind is unusually rich in a sour compound called hydroxycitric acid. That compound blocks one step the body uses to turn surplus sugar into stored fat, and it may also nudge serotonin, a brain chemical linked to appetite. On that basis the rind extract became one of the most heavily sold weight-management supplements in the world.

The rind itself is old and ordinary food. Across the Western Ghats of India, Sri Lanka and Southeast Asia it has been dried, smoked and used for centuries to sour fish curries, and in traditional practice as a digestive remedy. Its modern reputation grew from laboratory work on fat synthesis and then from a wave of television promotion that turned it into a mass-market product. Alongside that popularity, a file of reports of severe liver damage accumulated in hospital records.

This review examines what controlled human research shows about the extract’s effects on body weight, body fat and blood fats, what the liver-injury reports do and do not establish, and how the two sides of that ledger stand for people already working deliberately on long-term health.

View Review

Tea tree oil is a concentrated plant oil, steam-distilled from the leaves of an Australian shrub called Melaleuca alternifolia. One component, terpinen-4-ol, does most of the work: it dissolves into the outer coats of bacteria, yeasts and mites and destroys them on contact. The oil is sold worldwide in acne gels, mouthwashes and eyelid wipes, and as a small bottle of undiluted oil.

Australian troops carried it in field kits during the Second World War, and it returned to shelves in the 1980s as an inexpensive product sold without prescription. It is cheap, easy to obtain, and often used daily for years at a stretch. Repeated skin contact over long periods is also the setting in which allergic reactions to plant oils build up, so both sides of the ledger matter here.

This review examines what controlled human trials report for tea tree oil on skin, scalp and eyelids, and how large those effects are. It examines the safety record, including allergic reactions, eye injury, swallowing accidents and a contested claim about hormone effects in children, and it examines who funds the research on each side of that dispute.

View Review

Angelica sinensis — sold in the West as dong quai — is the dried root of a plant in the celery family that has been a fixture of Chinese herbal practice for roughly two thousand years. It is classified there as a “blood tonic,” and modern chemistry traces much of its activity to a small group of aromatic oils and plant acids that relax blood vessels and dampen inflammation.

The root reached Western shelves in the twentieth century mainly as a women’s remedy for menstrual pain and menopausal flushing, and it is now among the most widely traded Chinese herbs in the world. It is rarely taken alone in its country of origin, where practice almost always pairs it with other herbs — a habit that makes judging the root on its own unusually difficult.

This review examines what controlled human research shows about Angelica sinensis: where the root and the formulas built around it shift measurable outcomes, where careful trials have found nothing at all, and where the main safety questions sit, including its behaviour alongside blood-thinning drugs and in hormone-sensitive tissue.

View Review

Jujube red dates (Ziziphus jujuba) are the wrinkled, reddish-brown dried fruits of a small thorny tree grown across China, Korea, Iran, and increasingly the American Southwest. Sold loose in Asian markets and simmered into teas, soups, and porridges, they taste like a cross between a date and an apple. Beyond their culinary role they are among the most heavily used items in traditional Chinese herbal practice, where they are given to calm the mind, support digestion, and soften harsher herbs inside a formula.

The tree has been cultivated for more than four thousand years, and the dried fruit remains an everyday household staple across East Asia rather than a niche supplement. Modern interest was sparked by its unusual chemistry: the fruit is dense in sugars, yet also carries pectin-type fibres, plant acids, and one of the highest measured concentrations of a natural cell-signalling molecule found in any food.

This review examines what controlled human research shows about eating jujube red dates — where the effects are measurable, where the evidence stops, and what the concentrated sugar means for someone tracking metabolic health.

View Review

Black currant oil is pressed from the seeds left behind when black currant berries are juiced. Among plant oils it is unusual: it delivers meaningful amounts of fats from both major families at once — the omega-6 fat gamma-linolenic acid alongside the omega-3 fats alpha-linolenic acid and stearidonic acid. The other commercial sources of gamma-linolenic acid, evening primrose and borage, supply the omega-6 side alone.

Seed oils rich in gamma-linolenic acid entered clinical use in the 1980s, after researchers observed that people with inflamed joints and with eczema often carried low blood levels of this particular fat. Black currant oil followed, drawn from a byproduct of the juice industry, and was studied mainly in joint disease and in immune function in older adults. Unlike borage, it is naturally free of the plant compounds that can burden the liver.

This review examines what human studies show about black currant oil: where measurable effects have been demonstrated and where they have not, how the body handles the fats it supplies, which risks and interactions have been documented, and how the protocols reported in the literature are constructed.

View Review

White Atractylodes is the dried underground stem of a daisy-family plant grown mainly in eastern China. In traditional Chinese practice it is given to strengthen digestion, settle loose stools and shift retained fluid, and it appears in more formulas than almost any other herb in that system. Modern chemistry has pulled three quite different active fractions from it — a group of scented plant compounds, sugar polymers that feed gut bacteria, and a fragrant oil — part of why its reported effects range so widely.

Cultivated for more than seven centuries and recorded as a top-grade tonic in the earliest surviving Chinese herbal text, it remains one of the highest-volume medicinal plants in China today. It is rarely sold on its own in Western markets, and almost all human research has tested it inside multi-herb mixtures rather than alone.

This review examines what is actually known about White Atractylodes: which effects human trials support and which rest only on cells and animals, how the herb behaves in the body, what its risks and quality problems are, and how the research base shapes the confidence any of it can carry.

View Review

Tart cherry juice is pressed from the sour cherry, Prunus cerasus, usually the Montmorency variety, and sold as a ready-to-drink juice or a concentrate diluted with water. It is rich in the deep red pigments that colour the fruit and supplies traces of melatonin, the hormone that signals darkness to the brain — which is why a fruit juice sits in the recovery routines of athletes and the cupboards of people chasing better sleep.

Sour cherries have been grown as a preserving and baking fruit across Europe and the Middle East for centuries, and cherries have circulated as a folk remedy for joint pain and gout in North America for about seventy-five years. Laboratory interest is far more recent: sports scientists began testing the juice around hard exercise in the mid-2000s, and attention then widened to sleep and, from there, to several other health outcomes.

This review examines what controlled human research shows about tart cherry juice — which effects hold up, which are contested, what doses and timings were tested, what the sugar load amounts to, and who funded the work.

View Review

Sunflower oil is pressed from the seeds of the sunflower plant and ranks among the four most-used cooking oils in the world. Most of what is sold is unusually rich in a single omega-6 fat, and it carries more vitamin E than any other common kitchen oil. Plant breeding has also produced a second, quite different version in which that omega-6 fat is largely swapped for the same fat that dominates olive oil, so two products share one name on the shelf.

The oil moved from a Russian and Ukrainian farm crop into Western kitchens in the middle of the twentieth century, when heart-health advice encouraged replacing butter and lard with liquid plant oils. The same bottle now sits at the centre of a loud public argument: some regard it as a cheap, cholesterol-lowering staple, others as a modern industrial fat that human biology never adapted to.

This review examines what the evidence shows about sunflower oil — the two very different types now sold, what happens to the oil in a hot pan, and what human studies report on cholesterol and long-term survival.

View Review

Black chokeberry is a small, almost black berry from a North American shrub. Its colour comes from an unusually dense load of plant pigments and related compounds — among the highest concentrations measured in any edible fruit. That density is the reason the berry attracts attention: the same compound families are the ones studied for their effects on blood vessels, blood fats, and the body’s own repair and defence machinery.

The berry was a minor wild food until growers in Russia and Eastern Europe turned it into a commercial crop during the twentieth century. Juice and fruit preparations were sold there for high blood pressure and hardened arteries, and large plantations followed. Today the fruit reaches most people as juice, freeze-dried powder, or capsules of concentrated extract, often inside heart- or gut-focused formulas.

This review examines what controlled human trials and pooled analyses actually show for black chokeberry — chiefly for artery function, blood fats, and inflammation — and sets that against how well it is tolerated, how it interacts with drugs and other supplements, how products differ, and what is worth measuring before and during use.

View Review

Slippery elm (Ulmus rubra) is a North American tree whose inner bark, ground to a powder and stirred into water, swells within seconds into a thick, slippery gel. That gel is the entire point: it clings to the lining of the throat and gut, which is why the bark has been sold for generations as a throat lozenge and a digestive powder.

The bark was a food, a wound dressing and a throat remedy for the peoples of eastern North America, and nineteenth-century American surgeons carved it into swelling rods used to widen body passages. It is cheap and easy to buy, and today appears in a large share of commercial gut-support blends. Almost every human study has tested it inside a mixture of several plants.

This review examines what is known about slippery elm: how the gel is thought to work, which effects have been measured in people and which rest on laboratory work alone, what harms have been reported, how it is typically taken, and what quality and sourcing questions surround a product stripped from a declining wild tree.

View Review

Sumac is the dried, ground fruit of a Mediterranean shrub, used for centuries as a tart crimson seasoning across the Levant, Turkey, Iran, and Sicily. It is unusually dense in plant pigments and tannins — the same families of compounds that give berries their color and strong tea its astringency — and it registers among the highest antioxidant values measured in any common culinary spice. That chemistry is what pulled it out of the kitchen and into clinical research.

Healers around the Mediterranean reached for sumac for stomach complaints, wounds, and thirst long before anyone measured a blood marker. Over the past decade, small controlled studies, most of them run by university nutrition groups in Iran, have given gram-scale daily doses of the powder to adults with raised blood sugar or raised blood fats, and pooled summaries of that work have since appeared.

This review examines what that body of work shows about sumac’s effects on blood sugar, blood fats, and inflammation; where the findings are thin, small, or in conflict; what is known about safety, interactions, and sourcing; and how the spice is used in practice.

View Review

Stinging nettle (Urtica dioica) is a common perennial weed whose leaves, roots and seeds have been eaten and used as folk medicine across Europe and Asia for thousands of years. The plant is best known for the burning welts its hairs raise on bare skin, yet the same plant is sold today as a dried leaf tea, a root extract capsule and a spring vegetable. Interest in it spans blood sugar, prostate and urinary comfort, and seasonal sneezing — an unusually wide spread for a single plant.

Nettle root and nettle leaf are chemically different materials with different traditional uses, and they are often confused on product labels. In Germany the root extract has been sold for decades as a licensed remedy for urinary trouble in older men, while the leaf has a longer history as a spring tonic and a remedy for aching joints.

This review examines what controlled human research shows about stinging nettle, where the evidence is strong, where it rests on small or single trials, and what the plant’s hormone-related and allergy-related effects mean for people who track their own health markers closely.

View Review

Kelp is a group of large brown seaweeds that grow in cold coastal waters and have been harvested as food for centuries. It reaches the modern market in three forms: whole dried sheets and strips used in cooking, coarse granules sold as a salt substitute, and pressed tablets or capsules sold as a mineral supplement. Its main claim to attention is that it is the densest natural food source of iodine, the mineral the thyroid gland uses to build the hormones that set the body’s metabolic pace.

Kelp has been a daily staple in Japanese and Korean kitchens for more than a thousand years, and people in those countries take in far more iodine than Western dietary guidance assumes is safe. The same density that makes kelp attractive as a natural mineral source is also what makes accidental excess easy, because the amount in any given batch varies enormously.

This review examines what the published evidence shows about deliberate kelp intake — as food, powder, or capsule — for health and longevity: what it appears to do, at what intake, what can go wrong, and how much confidence the underlying research supports.

View Review

Bergamot oil is the fragrant oil pressed from the peel of the bergamot orange, a sour citrus fruit grown almost entirely on a narrow strip of the Calabrian coast in southern Italy. It is the scent that gives Earl Grey tea its character, and it is one of the most widely diffused, inhaled, and worn aromas in the world. Interest in it as a health intervention comes from a simple claim: that breathing it lowers stress.

Commercial use dates to the eighteenth century, first in perfume and later in tanning preparations that exploited its ability to make skin react strongly to sunlight — an application later withdrawn. Bergamot growers, fragrance houses, and aromatherapy sellers all have a stake in how the oil is described, which shapes the literature available on it.

This review examines what is known about bergamot oil: what it contains, how it is thought to act on the nervous system, what has been measured in people who have used it, and what is known about its effects on skin exposed to sunlight.

View Review

Evodia rutaecarpa is a small tree in the citrus family whose dried, unripe fruit has been a fixture of Chinese and Japanese herbal practice for roughly two thousand years. The fruit is sharply pungent and was classified as a “warming” remedy, given for headache, cold-type stomach pain, vomiting and long-standing morning diarrhoea. Modern interest centres on two of its plant compounds, evodiamine and rutaecarpine, which act on the same heat-and-pain sensor in nerve endings that chili pepper compounds act on.

That shared target is why the fruit reappeared in Western supplement catalogues as a fat-burning ingredient, frequently blended with stimulants. In parallel, the fruit has long carried a formal “slightly toxic” designation in Chinese herbal texts, and laboratory work has repeatedly flagged liver injury at higher intakes. Almost all of the published biology comes from cells and rodents; human data on the fruit itself remain very thin.

This review examines what the evidence shows about the effects attributed to Evodia rutaecarpa, how strong that evidence is, what safety signals accompany it, and how the fruit is dosed, sourced and monitored.

View Review

Sea buckthorn (also called seaberry) is a thorny shrub whose bright orange berries have been eaten as food and used as a folk remedy across Eurasia for centuries. Its berries, seeds, and leaves carry an unusual combination of vitamin C, orange plant pigments, and an uncommon fat that almost no other plant food supplies in quantity.

Soviet and Chinese researchers studied the plant intensively from the mid-twentieth century onward, and it holds a place in Chinese practice as both a food and a medicine. Interest outside Asia grew once the berry was recognized as a rich source of that uncommon fat, which appears to act less like a simple nutrient and more like a chemical message passing between fat tissue and muscle. Most human testing, however, has used whole berries or pressed oils rather than the isolated fat.

This review examines what controlled human testing shows about sea buckthorn: which measurable outcomes the berry and its oils shift, which they leave unchanged, how large the shifts are, what harms have been recorded, and how firmly the evidence supports each claim.

View Review

Banaba is a flowering tree of tropical South and Southeast Asia whose leaves have been brewed as a tea for generations. The leaves are unusually rich in plant compounds that appear to change how the body handles sugar, and modern supplements concentrate these into capsules. Interest centers on whether a leaf with a long, food-like history of use can meaningfully blunt the rise in blood sugar that follows a meal.

In the Philippines the boiled leaf tea has been a household remedy for high blood sugar for well over a century, and laboratory work on it began in the 1940s. Standardized extracts reached Western supplement shelves in the late 1990s, and the leaf now appears in a large share of blood-sugar and weight-management blends sold worldwide, almost always beside several other botanicals.

This review examines what the human and laboratory evidence shows about banaba leaf: which of its compounds are active, how large and how durable the effects on blood sugar and related markers appear to be, what harms and drug combinations have been recorded, and how the extracts sold today differ from the ones actually tested.

View Review

Muira puama is the root and bark of a small Amazonian tree, Ptychopetalum olacoides, sold for generations under the nickname “potency wood.” It is a common plant name rather than a botanical name, and it reaches Western shelves mostly as capsules and alcohol-based tinctures aimed at sexual desire, energy and mental sharpness. What makes it unusual is that its traditional reputation runs in two directions at once: a sexual tonic and a remedy for nervous exhaustion.

Amazonian communities prepared root infusions for weakness, nervous complaints and loss of sexual function long before the plant entered European herbal practice in the nineteenth century. Laboratory work in Brazil later pushed it toward the brain, while a separate line of work in the United States has tested it inside multi-ingredient formulas aimed at ageing blood vessels. Human testing of the herb on its own has stayed thin throughout.

This review examines what is genuinely established about muira puama: what its active parts do, what the human and animal studies actually show, where the evidence is thin or missing, what the safety and product-quality picture looks like, and how it is typically dosed and tracked.

View Review

Red spinach extract is a concentrated powder made from the leaves of amaranth plants, a leafy green eaten for centuries across Asia, Africa, and the Caribbean. It is sold because the leaves are unusually rich in nitrate, a natural compound the body turns into nitric oxide, the signal molecule that relaxes blood vessels and increases blood flow. One gram of the powder packs about as much nitrate as a large plate of leafy greens.

Interest grew once researchers established that nitrate from vegetables is recycled through saliva and converted into active forms by bacteria living on the tongue. Beetroot juice became the standard way to use that route, but it is bulky, sugary, and staining. Red spinach extract was introduced as a compact, sugar-free alternative, and a small set of trials in physically active adults followed.

This review examines what the evidence shows for red spinach extract: how much nitrate it actually delivers, whether that translates into measurable changes in blood pressure, blood flow, and exercise capacity, what is known about its safety, and where findings for the concentrated extract diverge from the much larger literature on nitrate from other sources.

View Review

Arnica is a yellow mountain flower of the daisy family that has been rubbed into bruised skin and aching joints across Europe for centuries. Today it reaches people in two very different forms: strong gels, creams and tinctures that carry measurable amounts of the flower’s active substances, and extremely diluted tablets and pellets in which almost nothing of the plant remains. Both are sold for the same purposes — easing bruising, swelling and soreness after injury, surgery or hard training.

Arnica is among the most widely sold plant remedies in the world, and it holds an unusual position. The same flower is treated as a useful anti-inflammatory when spread on unbroken skin and as a poison when swallowed at full strength. That split has produced a research record in which the preparation used matters as much as the plant itself.

This review examines what human studies show about arnica for joint pain, bruising, swelling and muscle soreness, how its strong and diluted forms differ in what they contain and what they do, what harms have been documented, and how sound the underlying evidence is.

View Review

Shatavari (Asparagus racemosus) is a climbing plant of the asparagus family whose thick, starchy roots have been used in Indian traditional medicine for around two thousand years. It is a close relative of the garden asparagus eaten as a vegetable, but a different species, and the root rather than the shoot is used. The root carries steroid-like plant compounds that can weakly attach to the same cell docking points the body’s own estrogen uses, which is why most interest has settled on women’s health.

In its home tradition the root is given after childbirth to support milk supply, during the years around the end of menstruation, and as a general restorative. Over the past decade it has moved out of that setting into capsules sold worldwide, and a run of placebo-controlled studies has begun testing claims that were previously carried by tradition alone. How much active root material a product actually contains varies enormously between brands.

This review examines what the human and laboratory evidence shows: where shatavari has been tested, what changed, what harms and product-quality problems have surfaced, and how solid the research behind each claim is.

View Review

Guar gum is a soluble fiber milled from the seed of the guar bean, a drought-hardy legume grown mainly in India and Pakistan. Stirred into water it forms a thick gel, which is why food makers use it to thicken ice cream, sauces and plant-based milks. That same gelling behavior slows how fast a meal leaves the stomach and how fast sugars and fats reach the bloodstream.

The ingredient has an unusual history. In the 1980s it was pressed into weight-loss tablets that swelled after swallowing; some lodged in the throat or gut, and regulators removed them from sale. An enzyme-treated version was then developed for hospital tube feeding: much thinner, easy to stir into a drink, and marketed today as a gut-health fiber. Both the original gum and the enzyme-treated form are sold as supplements.

This review examines what the evidence shows about both forms: where effects on cholesterol, blood sugar and bowel function hold up, where the findings disagree, which harms have been reported, and what the practical trade-offs of daily use look like.

View Review

Pumpkin seed extract is a concentrated preparation made from the seeds of the pumpkin plant, sold either as a cold-pressed oil or as an oil-free water-and-alcohol extract. Interest in it comes from two directions: long-standing folk use for bladder and prostate complaints, and a more recent line of research on pattern hair loss. The seeds are unusually rich in plant sterols, which resemble the body’s own steroid hormones closely enough to interfere with the enzymes that shape prostate and hair-follicle growth.

Pumpkin seeds have been eaten and used medicinally for centuries in the Americas and in central Europe, where a hull-less variety was bred specifically for oil pressing. German health authorities have listed the seed for bladder irritation and for urinary complaints accompanying prostate enlargement since the 1980s, which is why most of the clinical work has come out of Europe.

This review examines what controlled human research shows about pumpkin seed extract — the size and the consistency of its reported effects on urinary symptoms and on hair growth — together with its safety profile, the dosing patterns used, and the quality of the evidence supporting each claim.

View Review

Akarkara is the dried root of a small Mediterranean daisy that has been traded across North Africa, the Middle East, and South Asia for centuries. Chewing a fragment produces an unmistakable tingling, burning, and flood of saliva — the sensory signature of the fat-soluble compounds the root concentrates. That same chemistry underlies its two most persistent reputations: as a remedy pressed against aching teeth and gums, and as a tonic for male sexual vigor.

The root appears in classical Ayurvedic and Unani writings, and it remains a common ingredient in commercial men’s-health blends sold today. It is also a plant under pressure: wild collection has pushed the species onto conservation watch lists, and material sold under the Akarkara name is often substituted with cheaper look-alike roots that produce a similar tingle.

This review examines what is actually known about Akarkara — what its active compounds do in the body, which effects have been measured and in what kind of study, what harms have been documented, and how thin or solid the evidence is at each point.

View Review

Eleutherosides are a small family of plant compounds — chiefly eleutheroside B (also called syringin) and eleutheroside E — found in the root and stem bark of the shrub Eleutherococcus senticosus, sold as eleuthero or Siberian ginseng. They are the compounds manufacturers measure to certify that an extract is genuine and potent, and they are the compounds most often credited with the plant’s long reputation for sustaining stamina under strain.

The plant was studied intensively in the Soviet Union from the late 1950s onward, where preparations were given to factory workers, soldiers, divers and cosmonauts to hold up output under demanding conditions. European regulators now permit eleuthero root preparations for tiredness and weakness. Most of that testing, however, used whole extracts of uncertain strength, and the eleutheroside content of commercial products differs widely.

This review examines what is known about eleutherosides: how they are thought to act, what human testing shows and fails to show, where the evidence openly conflicts, what harms and product-quality problems have been documented, and how doses and preparations are chosen in practice.

View Review

Pinitol is a naturally sweet plant compound, closely related to the sugar alcohols, that is most concentrated in carob pods and soybeans and also occurs in pine needles, mangrove ferns and many legumes, where it helps plants hold water under salt and drought stress. Inside the body it behaves less like a food sugar than like a small signaling molecule, and most of the interest in it comes from reports that it nudges muscle and liver cells to handle glucose in a way that echoes part of what insulin does.

Carob has been a Mediterranean food staple for millennia, and pinitol-rich plants have long been prepared as traditional remedies for high blood sugar in India and southern Africa. Laboratory work on how insulin passes its message inside the cell later pointed to a family of related molecules, of which pinitol is by far the most abundant in ordinary food.

This review examines what the human and laboratory evidence shows about pinitol: how it appears to work, which blood sugar, liver and inflammation outcomes have been measured, where trials disagree, what is known about safety and dosing, and who paid for the research.

View Review

Green light therapy shines low-power light from the green part of the visible spectrum — roughly 515 to 530 nanometers — onto the scalp, usually from a helmet or cap fitted with small semiconductor lamps. It belongs to a family of light treatments in which light is absorbed inside cells and changes how they work, rather than heating or cutting tissue. The green band is a newcomer here.

For two decades the devices sold and studied for thinning hair have emitted red or near-infrared light instead. Pattern hair loss reaches about half of men by their fifties and many women after menopause, and the available medicines carry side-effect and daily-use burdens that push many people toward device-based options. Interest in green wavelengths grew after animal work hinted that they might rouse resting follicles at least as readily as red.

This review examines what is known about green light aimed at the scalp for hair regrowth: how it is proposed to act, what the human and animal evidence shows and where it stops, what risks and practical limits come with it, and how it compares with the better-studied red approach.

View Review

Green light therapy is the use of a narrow band of green light — close to the colour of a traffic signal’s go lamp — delivered from a lamp or light strip at low brightness for a fixed period each day. Interest in it comes from a plain clinical observation: people in the middle of a migraine attack find nearly every colour of light painful, but green much less so.

Light and headache have a long shared history. Retreating to a darkened room is among the oldest self-treatments for migraine, and the sensitivity to light that drives that retreat is one of the defining features of an attack. Laboratory work on how the eye passes light signals into pain-processing regions of the brain turned that everyday observation into a testable proposition: that one narrow slice of the visible spectrum might calm a headache rather than aggravate it. Consumer lamps built on that idea are now sold widely.

This review examines what the evidence shows about green light therapy for migraine — how it is thought to work, which benefits and harms have been measured, how it is used in practice, and how solid the underlying research is.

View Review

Plasmalogens (ether phospholipids) are a family of fats that make up roughly one in five of the building blocks of human cell membranes, and they are concentrated in the brain, heart, and immune cells. Their distinguishing chemical bond is easily broken by reactive oxygen, so they are widely described as membrane-level shock absorbers that are sacrificed to protect neighbouring molecules. Levels fall with age and fall further in people with dementia and Parkinson’s disease.

That observation turned an obscure lipid into a supplement. Scallops, sea squirts, chicken, and laboratory synthesis all now supply commercial products, and a Japanese research group ran the first placebo-controlled trials in people with early memory loss. Blood levels do rise when these products are taken by mouth, which is unusual for a large fat molecule and is the main reason the field has kept moving.

This review examines what plasmalogen supplementation has and has not been shown to do in humans, how the evidence was funded and designed, what the plausible harms are, and how the results read for people who are already tracking and managing their own long-term health.

View Review

Basil seeds are the small black seeds of the sweet basil plant, the same herb grown for its leaves. Dropped into water they swell within minutes into a gel-coated pearl, a texture that has made them a staple of chilled South Asian drinks and desserts for centuries. That gel is the reason they are now sold as a health food: it is a soluble fibre that thickens the contents of the stomach and gut and slows digestion.

Interest has grown as gel-forming fibres have moved toward the centre of nutrition science, and as basil seeds have been marketed alongside chia and flax as a source of plant omega-3 fat, calcium and iron. Traditional medicine in India, Iran and Thailand long used them for digestive complaints, and food scientists have studied the gum extracted from them far more thoroughly than the whole seed has been studied in people.

This review examines what is known about basil seeds for health and longevity: what the gel does inside the body, which effects have actually been measured in humans, what can go wrong, and how thin or how solid the evidence behind each claim really is.

View Review

Retinol is a form of vitamin A that is spread on the skin rather than swallowed. It is the most widely sold non-prescription member of a family of vitamin A compounds used to soften fine lines, even out patchy colour, and rebuild skin that has thinned with age and sun exposure. Skin cells convert it, through several steps, into the active form that changes how skin renews itself.

Prescription vitamin A creams have been used against facial ageing since the 1980s. Retinol reached cosmetic shelves as a gentler stand-in that needs no prescription, and it now appears in serums, night creams and eye products across a wide range of strengths. European regulators recently capped how much a cosmetic may contain, because vitamin A also builds up in the body from food and supplements.

This review examines what controlled human studies show about topical retinol for skin rejuvenation, how it compares with the prescription form, what irritation and other harms have been recorded, how the products are made and stored, and how much of the published evidence comes from the companies that sell them.

View Review

Abaloparatide, sold as Tymlos, is a laboratory-made copy of the active fragment of a natural human signalling protein that governs calcium handling and bone turnover. Given as a small daily injection under the skin, it belongs to a very small group of osteoporosis drugs that build new bone rather than merely slowing its breakdown — the mechanism of nearly every other bone drug in wide use.

Bone loss accelerates after menopause and continues in both sexes with age, and a broken hip in later life carries a high risk of lasting disability and earlier death. That makes skeletal strength a lifespan question rather than a cosmetic one. Regulators approved abaloparatide in 2017 for women past menopause facing a high chance of fracture, and later for men. Its maker positions it as a stronger, better-tolerated alternative to the older bone-building injection it competes with — a claim that has been tested but not settled.

This review examines what the evidence shows: how much abaloparatide raises bone strength and lowers fracture rates, how it compares with the alternatives, what side effects and open questions accompany it, how it is dosed and monitored, and what happens when it is stopped.

View Review

Two of the most widely prescribed medicine groups in the world were never designed to fight cancer. Statins lower cholesterol in tens of millions of people, and sildenafil and tadalafil were first sold to treat erectile dysfunction. Both are inexpensive, long off patent, and backed by decades of safety experience. Researchers have asked for years whether either might also slow tumors, and more recently whether the two together might do more than either alone.

Interest sharpened when laboratory work suggested the two act on the same resource from opposite directions: tumor cells need cholesterol to build membranes and to move, and each group restricts that supply by a different route. Prescription records have also hinted that people taking both while living with cancer fare somewhat better, although such records cannot separate a medicine from the kind of person who takes it.

This review examines what is known about pairing these two medicine groups against cancer: how the proposed joint mechanism is said to work, which human data exist and which questions they leave open, the side effects and interactions each partner brings, and how the pairing is used today outside its approved purposes.

View Review

Whey and casein are the two proteins in cow’s milk. When milk is separated to make cheese, the watery part that drains away is whey, and the curd left behind is casein. Both are sold as powders and rank among the most popular muscle-building supplements. The key difference is speed: whey digests quickly and floods the blood with amino acids in a short burst, while casein thickens in the stomach and releases its amino acids slowly over several hours.

Milk has been part of the human diet for thousands of years, but whey was long treated as a cheese-making waste product before it became a staple of the fitness world. Today the two proteins are often framed as rivals, with whey favored around workouts and casein favored before sleep. Both supply the full set of building blocks the body needs to maintain and repair muscle.

This review compares whey and casein side by side, looking at how their different digestion speeds affect muscle, body composition, aging, and overall health. It examines where each protein appears to hold an advantage, where they perform alike, and what the trade-offs are for people focused on long-term health and longevity.

View Review

THC (delta-9-tetrahydrocannabinol) is the main mind-altering compound in the cannabis plant and the molecule responsible for the “high” people associate with marijuana. It works mainly by mimicking natural signaling molecules the body already makes, plugging into the same cell receptors and nudging pain, mood, appetite, and sleep. Long treated purely as a recreational drug, THC has moved into mainstream medicine as legal access has spread and as a purified, prescription form has become available for nausea and appetite loss.

Interest for healthy aging comes from an unusual observation: while heavy use can harm a developing brain, very low doses appeared to sharpen memory and rejuvenate brain-cell connections in elderly animals, a pattern that does not hold in the young. Cannabis is now among the most widely used substances on earth, so its long-term effect on health is a large open question.

This review examines what the evidence shows about THC across the span of benefits and harms most relevant to health- and longevity-focused adults — where the signal is genuine, where it is preliminary, and where the risks outweigh the promise.

View Review